US20240008763A1 - Device and method for safe access and automated therapy - Google Patents
Device and method for safe access and automated therapy Download PDFInfo
- Publication number
- US20240008763A1 US20240008763A1 US18/472,625 US202318472625A US2024008763A1 US 20240008763 A1 US20240008763 A1 US 20240008763A1 US 202318472625 A US202318472625 A US 202318472625A US 2024008763 A1 US2024008763 A1 US 2024008763A1
- Authority
- US
- United States
- Prior art keywords
- sensor
- catheter
- fluid
- sensors
- pressure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 87
- 238000002560 therapeutic procedure Methods 0.000 title abstract description 22
- 238000003780 insertion Methods 0.000 claims description 33
- 230000037431 insertion Effects 0.000 claims description 30
- 230000008859 change Effects 0.000 claims description 21
- 238000004891 communication Methods 0.000 claims description 7
- 239000012530 fluid Substances 0.000 abstract description 125
- 238000001802 infusion Methods 0.000 abstract description 81
- 238000012544 monitoring process Methods 0.000 abstract description 43
- 210000001519 tissue Anatomy 0.000 description 88
- 230000000747 cardiac effect Effects 0.000 description 56
- 210000002700 urine Anatomy 0.000 description 43
- 210000004369 blood Anatomy 0.000 description 41
- 239000008280 blood Substances 0.000 description 41
- 230000002631 hypothermal effect Effects 0.000 description 25
- 206010016803 Fluid overload Diseases 0.000 description 22
- 210000003200 peritoneal cavity Anatomy 0.000 description 22
- 239000000126 substance Substances 0.000 description 22
- 210000001367 artery Anatomy 0.000 description 20
- 230000002093 peripheral effect Effects 0.000 description 19
- 238000005516 engineering process Methods 0.000 description 17
- 238000002106 pulse oximetry Methods 0.000 description 17
- 230000017531 blood circulation Effects 0.000 description 14
- 230000003287 optical effect Effects 0.000 description 14
- 230000036772 blood pressure Effects 0.000 description 13
- 210000001105 femoral artery Anatomy 0.000 description 12
- 238000005259 measurement Methods 0.000 description 12
- 230000002485 urinary effect Effects 0.000 description 12
- 230000002792 vascular Effects 0.000 description 12
- 210000004877 mucosa Anatomy 0.000 description 11
- 230000036284 oxygen consumption Effects 0.000 description 11
- 206010040047 Sepsis Diseases 0.000 description 10
- 210000000709 aorta Anatomy 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 210000003191 femoral vein Anatomy 0.000 description 10
- 238000006213 oxygenation reaction Methods 0.000 description 10
- 210000003371 toe Anatomy 0.000 description 10
- 210000003462 vein Anatomy 0.000 description 10
- 238000007912 intraperitoneal administration Methods 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- 230000000004 hemodynamic effect Effects 0.000 description 8
- 230000036571 hydration Effects 0.000 description 8
- 238000006703 hydration reaction Methods 0.000 description 8
- 102000001554 Hemoglobins Human genes 0.000 description 7
- 108010054147 Hemoglobins Proteins 0.000 description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 7
- 238000001990 intravenous administration Methods 0.000 description 7
- 239000001301 oxygen Substances 0.000 description 7
- 229910052760 oxygen Inorganic materials 0.000 description 7
- 230000001575 pathological effect Effects 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 239000003978 infusion fluid Substances 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 230000002262 irrigation Effects 0.000 description 6
- 238000003973 irrigation Methods 0.000 description 6
- 238000013480 data collection Methods 0.000 description 5
- 230000002496 gastric effect Effects 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 238000007917 intracranial administration Methods 0.000 description 5
- 230000000474 nursing effect Effects 0.000 description 5
- 206010033675 panniculitis Diseases 0.000 description 5
- 210000004304 subcutaneous tissue Anatomy 0.000 description 5
- 229940124597 therapeutic agent Drugs 0.000 description 5
- 102000009027 Albumins Human genes 0.000 description 4
- 108010088751 Albumins Proteins 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 210000003567 ascitic fluid Anatomy 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 230000018044 dehydration Effects 0.000 description 4
- 238000006297 dehydration reaction Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000003032 molecular docking Methods 0.000 description 4
- 230000000704 physical effect Effects 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 210000001631 vena cava inferior Anatomy 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 108010000849 leukocyte esterase Proteins 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000032456 Hemorrhagic Shock Diseases 0.000 description 2
- 206010020843 Hyperthermia Diseases 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010049771 Shock haemorrhagic Diseases 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 230000002939 deleterious effect Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 229940030606 diuretics Drugs 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 208000011316 hemodynamic instability Diseases 0.000 description 2
- 230000036031 hyperthermia Effects 0.000 description 2
- 230000036543 hypotension Effects 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 230000001926 lymphatic effect Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000003393 splenic effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 210000005166 vasculature Anatomy 0.000 description 2
- 230000002861 ventricular Effects 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 206010021137 Hypovolaemia Diseases 0.000 description 1
- 206010056658 Pseudocyst Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229940063711 lasix Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000000082 organ preservation Substances 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 238000002496 oximetry Methods 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 210000003281 pleural cavity Anatomy 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/06—Devices, other than using radiation, for detecting or locating foreign bodies ; determining position of probes within or on the body of the patient
- A61B5/065—Determining position of the probe employing exclusively positioning means located on or in the probe, e.g. using position sensors arranged on the probe
- A61B5/068—Determining position of the probe employing exclusively positioning means located on or in the probe, e.g. using position sensors arranged on the probe using impedance sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
- A61B5/02055—Simultaneously evaluating both cardiovascular condition and temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/20—Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
- A61B5/207—Sensing devices adapted to collect urine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/20—Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
- A61B5/207—Sensing devices adapted to collect urine
- A61B5/208—Sensing devices adapted to collect urine adapted to determine urine quantity, e.g. flow, volume
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/0085—Devices for generating hot or cold treatment fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/12—Devices for heating or cooling internal body cavities
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0001—Body part
- A61F2007/0018—Trunk or parts thereof
- A61F2007/0022—Abdomen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0059—Heating or cooling appliances for medical or therapeutic treatment of the human body with an open fluid circuit
- A61F2007/0063—Heating or cooling appliances for medical or therapeutic treatment of the human body with an open fluid circuit for cooling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0093—Heating or cooling appliances for medical or therapeutic treatment of the human body programmed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/12—Devices for heating or cooling internal body cavities
- A61F2007/126—Devices for heating or cooling internal body cavities for invasive application, e.g. for introducing into blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/0105—Steering means as part of the catheter or advancing means; Markers for positioning
- A61M2025/0166—Sensors, electrodes or the like for guiding the catheter to a target zone, e.g. image guided or magnetically guided
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3303—Using a biosensor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/04—Heartbeat characteristics, e.g. ECG, blood pressure modulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/08—Other bio-electrical signals
- A61M2230/10—Electroencephalographic signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/202—Blood composition characteristics partial carbon oxide pressure, e.g. partial dioxide pressure (P-CO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/205—Blood composition characteristics partial oxygen pressure (P-O2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/208—Blood composition characteristics pH-value
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/65—Impedance, e.g. conductivity, capacity
Definitions
- the present invention relates to the field of medical devices, in particular devices capable safely accessing bodily spaces or cavities.
- Fluids and other substances are infused into patients for a variety of reasons.
- fluids may be given to a patient intravenously to hydrate the patient or to control overall blood volume.
- Mantle US 2006/0161107 describes a system that extracts fluid from a body cavity, processes the fluid and then recirculates fluid back into the cavity. Mantle does not describe infusion of a fluid into a patient without extraction of the fluid from the patient, however. In addition, the parameters on which the Mantle system is controlled are limited.
- One aspect of the invention provides an automated therapy system having an infusion catheter; a sensor adapted to sense a patient parameter; and a controller communicating with the sensor and programmed to control flow output from the infusion catheter into a patient based on the patient parameter without removing fluid from the patient.
- the sensor may be incorporated into the catheter, and in other embodiments, the sensor may be separate from the catheter.
- the sensor may be, e.g., an ECG sensor; an EEG sensor; a pulse oximetry sensor; a blood pressure sensor; a cardiac output sensor; a thermodilution cardiac output sensor; a cardiac stroke volume sensor; a heart rate sensor; a blood flow sensor; a pH sensor; a blood pO 2 sensor; an intracranial pressure sensor; and/or a solute sensor.
- the catheter may be a peripheral venous catheter; a central venous catheter; an arterial catheter; or a peritoneal catheter (possibly incorporating an intraperitoneal pressure sensor).
- Another aspect of the invention provides a method of controlling infusion of a fluid to a patient.
- the method includes the following steps: monitoring a patient parameter with a sensor to generate a sensor signal; providing the sensor signal to a controller; and adjusting fluid flow to the patient based on the sensor signal without removing fluid from the patient.
- the method includes the step of monitoring cardiac output with the sensor and, possibly, adjusting fluid flow to the patient based on cardiac output monitored by the sensor.
- the patient parameter includes an electrocardiogram; an electroencephalogram; blood oxygen saturation; blood pressure; cardiac output; cardiac stroke volume; heart rate; blood flow; total circulating blood volume; whole body oxygen consumption; pH; blood pO 2 ; osmolarity; peritoneal cavity compliance; intrathoracic pressure; bladder pressure; and/or rectal pressure.
- the adjusting step includes the step of adjusting fluid flow to achieve or maintain patient euvolumia; adjusting flow of a therapeutic agent (such as a chilled medium) to the patient; adjusting fluid flow to the patient through a peripheral venous catheter; adjusting fluid flow to the patient through a central venous catheter; adjusting fluid flow to the patient through an arterial catheter; and/or adjusting fluid flow to the patient's peritoneal cavity.
- a therapeutic agent such as a chilled medium
- Yet another aspect of the invention provides a method of treating hypotension in a patient.
- the method includes the following steps: monitoring a patient parameter (such as blood pressure or cardiac output) with a sensor to generate a sensor signal; providing the sensor signal to a controller; and adjusting fluid flow to the patient based on the sensor signal without removing fluid from the patient.
- a patient parameter such as blood pressure or cardiac output
- Still another aspect of the invention provides a method of treating sepsis in a patient.
- the method includes the following steps: monitoring a patient parameter (such as blood pressure, central venous pressure, or cardiac output) with a sensor to generate a sensor signal; providing the sensor signal to a controller; and adjusting fluid flow to the patient based on the sensor signal without removing fluid from the patient.
- a patient parameter such as blood pressure, central venous pressure, or cardiac output
- Yet another aspect of the invention provides a method of inducing and reversing therapeutic hypothermia in a patient.
- the method includes the steps of: monitoring intracranial pressure to generate a sensor signal; providing the sensor signal to a controller; and adjusting rate of hypothermia induction or rewarming based on intracranial pressure (such as by adjusting fluid flow to the patient), or depth of hypothermia, based on the sensor signal.
- irrigation and/or lavage of bodily tissues, cavities or spaces may be optimized using a sensor or sensors to report electrical, chemical, acoustic, mechanical properties, pressure, temperature, pH or other parameters surrounding the access device in order to automate and optimize the irrigation/lavage.
- Embodiments of the invention include a peritoneal catheter containing one or more sensors which may detect changes in electrocardiograph monitoring, electroencephalograph monitoring, pulse oximetry (either internally or peripherally), peritoneal cavity compliance, intrathoracic pressure, intraperitoneal pressure, intraperitoneal pressure waveforms, bladder pressure, rectal pressure, cardiac output, cardiac stroke volume, cardiac rate, blood flow (e.g., in superior mesenteric, celiac, renal or other arteries), pressure in veins (particularly the inferior vena cava or those that empty into the inferior vena cava, e.g., femoral vein), pressure in arteries (particularly those distal to the aorta, e.g., the femoral artery), total circulating blood volume, blood oxygenation (e.g., in rectal mucosa, peripheral fingers and toes, etc.), whole body oxygen consumption, pH and/or arterial pO 2 (or any other parameter that shows a measurable change with increased peritoneal pressure
- Embodiments of the invention include an intravascular catheter containing one or more sensors which may detect changes in electrocardiograph monitoring, electroencephalograph monitoring, pulse oximetry (either internally or peripherally), partial pressure of oxygen or CO 2 , pH, temperature, blood pressure, central venous pressure, cardiac output, cardiac stroke volume, cardiac rate, blood flow (e.g., in superior mesenteric, celiac, renal or other arteries), total circulating blood volume, pressure in veins (particularly those that empty into the inferior vena cava, e.g., femoral vein), pressure in arteries (particularly those distal to the aorta, e.g., the femoral artery), blood oxygenation (e.g., in rectal mucosa, peripheral fingers and toes, etc.), whole body oxygen consumption, pH and/or arterial pO 2 (or any other parameter that shows a measurable change with intravascular volume overload) to ensure safety of manual or automated intravascular infusion.
- the invention also includes methods of using such devices.
- inventions include control of the rate of infusion to minimize negative effects observed by the sensors.
- the invention may be used to induce and/or maintain hypothermia or hyperthermia; maximize hydration and/or intravascular volume in a patient receiving intravenous fluids (such as, e.g., post-operative patients, post-hemorrhage patients, septic patients or other intensive care patients).
- Fluid detection may be fully automated and the user may be alerted if volumes become too low or too high.
- the data may also be automatically routed to a centralized data collection server so that it may be collected and accessed without the requirement for nursing or other healthcare personnel to record the information manually.
- the output receptacle in particular, may contain wireless technology, ie RFID, as well to optimize data collection and reduce nursing burden.
- the present invention may also measure and report bladder temperature in real-time and this information may be used to alert the healthcare providers of changes in therapy and/or may be used to control and direct depth of therapeutic hypothermia.
- the reservoir/receptacle may also contain sensors capable of detecting other materials of interest within the fluid including, but not limited to: hemoglobin, blood, bacteria, leukocyte esterase, glucose, protein, particulate matter, etc. This information may also trigger an alert to provide real-time data monitoring of these parameters.
- the present invention anticipates the use of wired or, ideally, wireless transmission of data to allow for centralized collection of data and centralized reporting. This is, once again, useful in reducing healthcare provider burden by allowing fewer personnel to monitor the data from all of the patients utilizing said system.
- the system of the present invention anticipates the use of RFID technology within or attached to the reservoir itself which may be remotely queried and interrogated by one or more RFID readers.
- the data collected may be encrypted and specific to each receptacle such that the up.ne output reported may be securely associated with an individual patient.
- the reservoir may contain conducting channels connected to the RFID circuitry which determine the urine level by detection of the level of a simple short-circuit through the conducting fluid itself which may then be reported by the RFID chip to the reader. This cheap, easy-to-use system overcomes the obstacles of previous attempts to automate urine output monitoring.
- information collected using the present invention may be used to automatically adjust therapeutic hypothermia, delivery of medicine or other interventions.
- the improved safety of the current invention is based, in part, on the ability of the access system to report entrance into the tissue/space/cavity via an integrated sensor.
- additional sensing capabilities may be incorporated, as well, to optimize the automated therapy delivered or intervention required.
- the disclosed invention is a method and device for safe access of a bodily tissues, spaces or cavities.
- the improved safety of the current invention is based, in part, on the ability of the access system to report entrance into the tissue, space, or cavity via a sensor integrated within, or inserted simultaneously with, the instrument itself. In its preferred embodiment, additional sensing capabilities may be incorporated, as well, to optimize the desired intervention or therapy to be delivered.
- a device for accessing bodily tissues, spaces or cavities outside of the respiratory tree wherein; said access device or its insertion instrumentation incorporates a sensor and wherein said sensor may report access to the desired tissues, spaces or cavities
- the device of 2 wherein said cavity to be accessed may be the peritoneal cavity, and wherein said sensor may directly or indirectly detect entry into this cavity.
- the device of 4 wherein said additional sensors may directly or indirectly detect mechanical properties (such as pressure), chemical composition, thermal properties, electrical properties, acoustic properties or optical ⁇ properties to optimize filling of the peritoneal cavity with gases, liquids and/or solids.
- the device of 2 wherein said cavity to be accessed may include peritoneal, pleural, cerebrospinal, biliary, gastrointestinal, gastric, intestinal, urinary cavities, or pathologic tissues, and wherein said sensor may directly or indirectly detect entry into this cavity.
- the device of 2 wherein said space to be accessed may include the cardiovascular, venous, arterial, lymphatic, ureteral cerebrospinal ventricular spaces, or pathologic spaces and wherein said sensor may directly or indirectly detect entry into this space.
- the device of 2 wherein said tissues to be accessed may include lung, liver, heart, bladder, brain, intestinal, pancreatic, splenic, vascular tissues, or pathologic spaces and wherein said sensor may directly or indirectly detect entry into these tissues.
- the method of 31 wherein said cavity to be accessed may include peritoneal, pleural, cerebrospinal, biliary, gastrointestinal, gastric, intestinal, urinary cavities, or pathologic spaces and wherein said sensor may directly or indirectly detect entry into one or more of these cavities.
- said space to be accessed may include the cardiovascular, venous, arterial, lymphatic, ureteral cerebrospinal ventricular spaces, or pathologic spaces and wherein said sensor may directly or indirectly detect entry into one or more of these spaces.
- tissue to be accessed may include lung, liver, heart, bladder, brain, intestinal, pancreatic, splenic, vascular tissues, or pathologic spaces and wherein said sensor may directly or indirectly detect entry into one or more of these tissues.
- one or more sensors may be used to provide multiple data points to help determine the exact position of said sensor or sensors.
- irrigation and/or lavage of bodily tissues, cavities or spaces may be optimized by said additional sensors and wherein said access device contains a sensor or sensors to report electrical, chemical, acoustic, mechanical properties, pressure, temperature, pH or other parameters surrounding the access device in order to optimize said irrigation/lavage.
- a peritoneal catheter containing one or more sensors which may detect changes in electrocardiograph monitoring, electroencephalograph monitoring, pulse oximetry (either internally or peripherally), peritoneal cavity compliance, intrathoracic pressure, intraperitoneal pressure, bladder pressure, rectal pressure, cardiac output, cardiac stroke volume, cardiac rate, blood flow (i.e. in superior mesenteric, celiac, renal or either arteries), pressure in veins (particularly those that empty into the IVC, i.e. femoral vein), pressure in arteries (particularly those distal to the aorta, i.e. the femoral artery), blood oxygenation (i.e.
- a method of performing peritoneal lavage wherein changes in electrocardiograph monitoring, electroencephalograph monitoring, pulse oximetry (either internally or peripherally), peritoneal cavity compliance, intrathoracic pressure, intraperitoneal pressure, bladder pressure, rectal pressure, cardiac output, cardiac stroke volume, cardiac rate, blood flow (i.e. in superior mesenteric, celiac, renal or other arteries), pressure in veins (particularly those that empty into the IVC, i.e. femoral vein), pressure in arteries (particularly those distal to the aorta, i.e. the femoral artery), blood oxygenation (i.e.
- An intravascular catheter containing one or more sensors which may detect changes in electrocardiograph monitoring, electroencephalograph monitoring, pulse oximetry (either internally or peripherally), partial pressure of oxygen or C02, pH, temperature, blood pressure, central venous pressure, cardiac output, cardiac stroke volume, cardiac rate, blood flow (i.e. in superior mesenteric, celiac, renal or other arteries), total circulating blood volume, pressure in veins (particularly those that empty into the IVC, i.e. femoral vein), pressure in arteries (particularly those distal to the aorta, i.e. the femoral artery), blood oxygenation (i.e. in rectal mucosa, peripheral fingers and toes, etc.), whole body oxygen consumption, pH and/or arterial p02 (or any other parameter that shows a measurable change with intravascular volume overload) to ensure safety of manual or automated intravascular infusion
- a method of performing intravascular infusion wherein one or more sensors may detect changes in electrocardiograph monitoring, electroencephalograph monitoring, pulse oximetry (either. internally or peripherally), partial pressure of oxygen or C02, pH, temperature, blood pressure, central venous pressure, cardiac output, cardiac stroke volume, cardiac rate, blood flow (i.e. in superior mesenteric, celiac, renal or other arteries), total circulating blood volume, pressure in veins (particularly those that empty into the IVC, i.e. femoral vein), pressure in arteries (particularly those distal to the aorta, i.e. the femoral artery), blood oxygenation (i.e. in rectal mucosa, peripheral fingers and toes, etc.), whole body oxygen consumption, pH and/or arterial p02 (or arty other parameter that shows a measurable change with intravascular volume overload) which may be used to regulate the rate of infusion
- FIG. 1 shows an automated infusion system in which infusion is controlled based on patient parameters sensed by multiple sensors.
- FIG. 2 shows an automated infusion system in which a sensor controlling infusion is separate from the infusion catheter.
- FIG. 3 shows an automated infusion system in which sensing and infusion are performed with the same catheter.
- FIG. 4 Conssole with optional sensor lead (may be wireless).
- FIG. 5 Sensor-based Urine Output Measurement.
- FIG. 6 Conssole with automated infusion therapy system.
- FIG. 7 Volume-sensing Urine Receptacle with Dock.
- FIG. 8 Volume-sensing Urine Receptacle—RFID Embodiment.
- FIGS. 9 A- 9 D Segment view of the sensor incorporated into the instrument.
- FIGS. 10 A- 10 E Segment view of the sensor incorporated into removable insertion trocar.
- FIGS. 11 A- 11 E Side view of the sensor Incorporated into removable sheath.
- FIGS. 12 A- 12 C Segment view of the External Reader attached to Access Device.
- FIGS. 13 A- 13 D Side view of the continuous reader incorporated into Access Device (trocar embodiment).
- FIGS. 14 A- 14 D Segar embodiment
- FIGS. 15 A- 15 E Side view of the sensor incorporated into access device (shown as catheter with insertion trocar).
- FIG. 16 Intravenous fluid flow automated by sensors.
- FIGS. 1 - 3 show embodiments of the invention wherein intravenous fluid delivery may be automated, or manually adjusted, based on feedback from one or more sensors.
- the infusion catheter may have a sensor to aid in insertion, but this is not necessary for this invention.
- FIG. 1 shows an infusion system with an infusion controller 10 operably connected to an intravenous infusion catheter 12 via an infusion line 14 .
- Infusion catheter 12 also has a sensor (not shown) attached to or associated with it to monitor a patient parameter. The sensor also communicates with controller 10 either through line 14 or via some other communication channel.
- Suitable patient parameters include electrocardiograph monitoring, electroencephalograph monitoring, pulse oximetry (either internally or peripherally), blood pressure, central venous pressure, cardiac output, cardiac stroke volume, cardiac rate, blood flow (e.g., in superior mesenteric, celiac, renal or other arteries), total circulating blood volume, pressure in veins (particularly those that empty into the inferior vena cava, e.g., femoral vein), pressure in arteries (particularly those distal to the aorta, e.g., the femoral artery), blood oxygenation (e.g., in rectal mucosa, peripheral fingers and toes, etc.), whole body oxygen consumption, pH, arterial pO 2 , or any other parameter that shows a measurable change with intravascular volume overload.
- additional catheters here envisioned as a peripherally inserted central catheter (PICC) 16 and/or a peritoneal catheter 18 , or additional sensors on infusion catheter 12 may be used to monitor these or other parameters, and to optimize the infusion rate and achieve euvolemia without fluid overload or dehydration.
- Flow of fluid and/or a fluid/solid mixture (e.g., an ice slurry) to catheters 16 and/or 18 is controlled by controller 10 through lines 14 , 15 and/or 17 , respectively.
- the information from the sensors may then be transmitted to central controller 10 , which integrates all of this information to determine the flow of intravenous fluid through catheter 12 and/or catheter 16 and flow of peritoneal fluid through catheter 18 .
- This information may be used to achieve or maintain euvolemia (e.g., in sepsis, hemorrhagic shock, etc.) or to maximize infusion for delivery of a therapeutic agent, e.g., chilled fluid and/or solids to achieve hypothermia.
- catheters 16 and 18 may be used with sensors to obtain patent information, and fluid may be infused into the patient solely through catheter 16 or catheter 18 .
- the depth of hypothermia and/or rate of hypothermia induction or rewarming may be tailored based on intracranial pressure sensor(s) (not shown) communicating with controller 10 via communication line 35 .
- This system and method may be used with any method of inducing hypothermia (e.g., cooling blankets, intravascular catheters, intravenous fluid infusion, peritoneal lavage, etc.) so long as the change in temperature, particularly rewarming, is controlled at least in part by an intracranial pressure sensor.
- hypothermia e.g., cooling blankets, intravascular catheters, intravenous fluid infusion, peritoneal lavage, etc.
- the sensor or sensors may also be separate from the infusion line so long as the information from this sensor or sensors is transferred to the control unit in order to optimize fluid flow.
- the patient parameter sensor may be associated with PICC 24 and communicate with controller via line 26 , and infusion to the patient may be via line 22 and infusion catheter 20 , as controlled by controller 10 .
- sensing and infusion may be performed through a single catheter, such as PICC 30 , and controlled by controller 10 through lines 32 and 34 , as shown in FIG. 3 .
- the infusion and monitoring device of the current invention may incorporate an access sensor, such as that described in a commonly owned patent application, U.S. patent application Ser. No. 12/098,355, filed Apr. 4, 2008, titled “Device And Method For Safe Access To A Body Cavity”.
- a peripheral venous, central venous or arterial catheter that is capable of maintaining hydration without causing fluid overload.
- the catheter may incorporate a sensor that may detect central venous pressure, total circulating blood volume, peripheral venous pressure, cardiac output or osmolarity, and/or solute concentrations (e.g., chloride, sodium, etc.) in order to prevent fluid overload.
- the sensor may also be external to the catheter, so long as the output of said sensor is capable of controlling fluid flow through the catheter.
- fluid flow is controlled by the output of the sensor, which is integrated by a fluid flow control unit which alters the rate of fluid flow based on this output.
- This embodiment may allow the user to bolus large volumes of fluids or solids into the vascular space in order to rehydrate, induce hypothermia or reverse hypothermia, or deliver a therapeutic agent or maintain blood pressure in sepsis.
- this technology may provide a fully automated mechanism to optimize fluid flow into the vessel without fluid overloading the patient. Without this automated fluid delivery coupled to hemodynamic parameter monitoring, the patient is in danger of dehydration or fluid overload from infusion of fluid into any body cavity.
- This technology may also be applied to liquid or solid infusion into any body cavity or space in so long as the fluid flow is automated based on feedback from sensors within the body (possibly incorporated into the catheter itself) in order to optimize the volume of infusion.
- This device and method of automating fluid flow based on hemodynamic sensor-based feedback may also be used to generate intravenous hypothermia.
- IV hypothermia induction is limited due to concerns of fluid overload.
- the hemodynamic parameters of the patient can be measured and fluid flow directly or indirectly controlled based on the output of these measurements, the volume of fluid can be maximized while ensuring hemodynamic instability.
- the sensor may be incorporated within the catheter, and fluid flow into the vasculature may be tailored based on central venous pressure, total circulating blood volume, peripheral venous pressure, cardiac output or osmolarity, and/or solute concentrations (e.g., chloride, sodium, etc.) in order to prevent fluid overload.
- the fluid infusion catheter also may function as a thermodilution cardiac output sensor such that the same fluid that is used to generate hypothermia may also be used to detect cardiac output. This information may then be relayed, either directly or indirectly, back to the fluid infusion controller to increase, decrease or even halt fluid flow based on these parameters. For example, if cardiac output is low and venous pressure or total circulating volume is low, the patient has a low circulating volume and large volumes of fluid may be safely delivered. If the cardiac output is normal, fluid may also be safely delivered, but the cardiac output must be monitored to ensure that it does not begin to decrease (an indication of fluid overload). Blood flow, as detected by, for instance, thermodilution may be determined in a peripheral vessel as well.
- This same system may be used to infuse normal fluids or hypothermic fluids to sepsis patients or patients requiring intensive maintenance of their hemodynamic status. Sepsis patients that are aggressively monitored do much better than those that are not. Aggressive monitoring is very nurse-intensive, however.
- a system that provides automated optimal fluid infusion based on sensed parameters to ensure that fluid overload does not occur and that fluid infusion is not insufficient would be an improvement over current methods of treating sepsis patients.
- the devices and methods for automated sensor-based input to control fluid flow to a patient may be applicable to a wide range of conditions and should not be limited to the narrow scope of the conditions requiring fluid infusion described here.
- the logic controller of the present invention may provide improved safety by monitoring for any of the deleterious changes expected with excess fluid flow, e.g., into the peritoneal cavity or vascular space.
- monitored parameters that may signal a warning or automatically result in an adjustment to rate of fluid infusion/extraction and/or fluid temperature include: electrocardiograph monitoring, electroencephalograph monitoring, pulse oximetry (either internally or peripherally), peritoneal cavity compliance, intrathoracic pressure, intraperitoneal pressure, intraperitoneal pressure waveforms, bladder pressure, rectal pressure, cardiac output, cardiac stroke volume, cardiac rate, total circulating blood volume, blood flow (e.g., in superior mesenteric, celiac, renal or other arteries), pressure in veins (particularly those that empty into the IVC, e.g., femoral vein), pressure in arteries (particularly those distal to the aorta, e.g., the femoral artery), blood oxygenation (e.g., in rectal mucosa, peripheral fingers and to
- FIG. 4 illustrates a console 40 with optional sensor lead 44 which may or may not be wireless.
- the console itself may record output/input data 42 . This data may be held in memory, printed or directly transmitted to a centralized data collection server. Said console may connect to the urine receptacle 46 to determine urine output either via a wire or wirelessly.
- FIG. 5 illustrates sensor-based Urine Output Measurement.
- the console 50 or RFID reader can trigger alert if urine output is too low or too high over a set period of time.
- the device may include an optional Docking Station 54 —ideally reusable, may connect to receptacle 52 and transmit data to control unit either via wires or, ideally, wirelessly. May also measure urine level via weight, etc.
- Optional Urine Level Sensors 56 may report level of urine via conductivity, resistance, impedance, etc. Sensors may also continuously or intermittently detect bacteria, hemoglobin or other substances of interest in urine.
- Urinary catheter 58 is also shown.
- FIG. 6 illustrates a console 60 with automated infusion therapy system.
- Console may integrate patient data, ie fluids received, urine output recorded, etc. to automate therapy, ie delivery of fluids or LASIX if the pt is dehydrated or fluid overloaded respectively. May also trigger local alert (ie beeping) and centralized alert (ie system alarm) if urine output drops too low.
- the console may also integrate a fluid infusion or medicine infusion capabilities, ie an IV infusion pump, and may adjust infusion rates based on this data or data acquired from other sensors in an automated fashion.
- the console may communicate wirelessly, as well, to these and any other sensors within the body.
- Infusion catheter 62 is also shown—may deliver drugs or fluid based on urine output and other parameters.
- Urinary catheter 64 is also shown.
- FIG. 7 illustrates a volume-sensing Urine Receptacle with reusable communicating and/or sensing element.
- the receptacle 70 itself may detect urine output based upon level at which sensors are triggered—ie have hash-marks represent electrical contacts and when an electrical path is made between two contacts, and all contacts below, the level can be reported at that level.
- the docking station may be connected anywhere on said receptacle, or optionally, not included at all. If a docking station is used, it may detect urine output based simply upon weight or pressure applied to base.
- This or the receptacle itself may contain an inductive antenna and/or RFID capabilities to allow for wireless querying and reporting of the level of urine or other fluid collection.
- FIG. 8 illustrates a volume-sensing Urine Receptacle 80 with RFID capabilities.
- This embodiment may contain RFID circuitry to collect and transmit data directly from within the receptacle to a RFID Reader. When queried by the RFID reader may simply detect impedance, resistance, capacitance or any other electrical or nonelectrical property to detect the urine level and report this back to the reader. Reader may then trigger alert if urine output is high or low.
- the RFID chip may be capable of detecting changes in optical, chemical, electrical, acoustic or mechanical properties, as well. May be active or passive RFID and may contain antenna in any position and, ideally, may transmit a unique signal to identify the receptacle to the reader and allow multiple receptacles to be queried at once.
- the RFID chip may incorporate a small battery (to extend its range) in an active RFID embodiment or may be passive in nature and be powered solely by the transmissions from said RFID reader.
- the RFID Reader 82 may query device from a distance to wirelessly check the urine output level or may be centralized to query all receptacles within a unit, floor or hospital and issue an alert if urine output drops too low (or is too high). May record urine output, as well, and replace the individual unit consoles illustrated in FIGS. 1 - 3 .
- the RFID reader may also report data from other sensors within said system, including bladder temperature or presence of certain materials within the urine, ie blood, hemoglobin, leukocyte esterase, other indicators of bacterial infection, protein, glucose, etc.
- a urinary catheter capable of sensing physiologic parameters. Additional sensing capabilities may include: blood pressure, oxygen saturation, pulse oximetry, heart rate, EKG, capillary fill pressure, etc.
- pulse oximetry technology to allow for blood oxygen concentration or saturation determination with a urinary catheter is envisioned.
- This device may function by incorporating pulse oximetry capabilities anywhere along the length of the catheter, but ideally the sensor or sensors will be contained within the tubing of the device to ensure approximation to the urethral mucosa. With this invention, the healthcare provider will be able to decompress the bladder with a urinary catheter and obtain pulse oximetry data in a repeatable and accurate manner.
- the power source for this device may be incorporated within the urinary drainage bag or within the catheter itself.
- the pulse oximeter will be reusable and the catheter interface will be disposable wherein the pulse oximeter is simply reversibly attached to the disposable catheter and removed once measurements of oxygen are no longer desired.
- the urinary catheter may contain an optically transparent, or sufficiently transparent, channel for the oximetry signal, ie a fiber-optic cable, transparent window, etc., and an interface for the reusable oximeter and otherwise be a standard urinary catheter.
- This method and device for urethral pulse oximetry may be used in conjunction with any of the other embodiments detailed herein or may be a stand-alone device in and of itself.
- the novel access system involves the use of a puncturing instrument in conjunction with a sensor at, or near, the tip of the instrument.
- This sensor may be capable of detecting changes within its environment in order to report that it has passed from the subcutaneous tissues into the desired cavity, space or tissue.
- a novel peritoneal access catheter is envisioned which is capable of detecting differences between the vascular, extraperitoneal, intestinal and intraperitoneal spaces.
- This sensor may detect I) changes in the physical properties surrounding the instrument such as pressure, acceleration, forces or other physical properties, 2) chemical changes surrounding the instrument, ie the presence or absence of compounds such as albumin, hemoglobin, glucose or the pH or other chemical properties, or 3) changes in the electrical properties such as conductance, resistance, impedance, capacitance, etc. of the tissues 4) changes in the acoustic or vibratory properties of the tissues, 5) changes in optical properties such as refraction of light within the tissue, or 6) changes in any other parameter that is able to be sensed via a sensor placed on, in, within or otherwise attached to or in communication with said instrument.
- the sensing element of said device may be incorporated in instrument itself, may be introduced along with the instrument or may be external to the instrument and communicate through a channel in said instrument.
- the sensor is incorporated into either in the instrument or its introducer and is able to provide immediate, definitive feedback that the correct body cavity has been accessed.
- the electrical properties of blood are different from that of air, the epidermis, the subcutaneous space, the fascia and the adventia of the vessel.
- the arterial access device ie a catheter with a sharp insertion trocar/needle
- a sensor in the catheter or insertion trocar/needle in this case electrical
- the sensed parameter in this case inductance, resistance, capacitance, etc.
- Another embodiment comprises the use of heat differentials to guide a catheter/needle to the appropriate space/tissue. For example, by placing a cold pack on the skin over the femoral artery, a temperature differential will exist with the warmest location being in the intravascular space. A temperature sensing catheter can be guided to the warmest location which would be inside the vessel.
- This sensing technique may be employed with virtually any invasive instrument to ensure correct placement via detection of changes in any of the aforementioned parameters (i.e. physical, chemical, thermal, electrical, acoustic/vibratory, optical or other parameter capable of being sensed) with the only requirement being that the target tissue or space within the body must have a sufficiently distinct sensor reading that it may be distinguished from its surrounding tissues.
- any of the aforementioned parameters i.e. physical, chemical, thermal, electrical, acoustic/vibratory, optical or other parameter capable of being sensed
- invasive instruments may include, but are not limited to instruments, catheters or devices intended to access the following spaces/tissue: peritoneal cavity or fluid (ie paracentesis or peritoneal lavage), vascular fluid or space (arterial catheter, intravenous catheter, etc.), cerebrospinal fluid or space, pleural or pulmonary fluid or space (ie chest tubes), pericardial or cardiac space or tissue, urologic fluid or space (ie suprapubic catheters), gynecologic access (ie fallopian tubes or ovaries), gastrointestinal fluid or space (ie nasogastrostomy or gastrostomy tubes), ocular or bulbar tissues or spaces, neurological tissue or space (ie brain biopsy instruments), pathological tissue or space (ie abscess, hematoma, cyst, pseudocyst), bone marrow tissue or space, or any other tissues or spaces that may be accessed minimally invasively, percutaneously or through a natural orifice.
- the sensing element may be disposable or reusable.
- the sensing element may be incorporated reversibly or irreversibly into the instrument itself, into the instrument's sheath, into the instrument's trocar, or kept external to said instrument with movement of gases, fluids or solids down the length of the instrument to the externally located sensor continuously or upon activation.
- Said sensor may also communicate wirelessly from the instrument to an external receiver removing the requirement for a tethering cord and allowing for a disposable and reusable component.
- the controller/reader may alert the user that access has been obtained through tactile, auditory, visual or any other _stimuli.
- the sensing may occur continuously or only upon command by the user (ie once they suspect that they are in the tissue or cavity).
- FIGS. 9 A- 9 D show side views of the sensor incorporated into the instrument.
- the instrument 91 in this case a needle or trocar
- the instrument 91 contains a sensor 92 at its tip which may intermittently or continuously provide information to the user to indicate plane of insertion.
- the instrument is shown passing through the subcutaneous tissues and muscular layers 93 and entering the cavity 95 without harming or penetrating the tissues beneath. Examples where this illustration apply include: peritoneal cavity access, pleural cavity access, cerebrospinal cavity access, etc.
- the same sensor, or another sensor may be capable of detecting other components that signal an issue may have occurred during entry.
- the sensor, or another sensor may be able to detect the presence of fecal matter or blood which would indicate that even though the cavity may have been entered, the catheter may been over-inserted or is not in its correct position.
- One example of this embodiment is a peritoneal access catheter with an electrical inductance sensor at its tip.
- the subcutaneous space has a different inductance compared to the peritoneal space which also has a different inductance than the intestinal lumen.
- the catheter may be advanced until the subcutaneous tissue inductance readings change to the peritoneal cavity inductance levels. Once the peritoneal cavity is sensed, based on the change in electrical properties, the catheter then provides feedback that the cavity has been accessed. In the event that the catheter is over-inserted into the bowel, the inductance will be dramatically lower than that found in the subcutaneous tissue or peritoneal space and this complication can be rapidly reported.
- iron-rich blood has a higher inductance than any of the other tissues and exposure to concentrated blood can be quickly reported if the catheter experiences this fluid.
- the cutoff may be set, as well, so that dilute blood does not trigger the sensor since minor capillaries may be ruptured in the normal access procedure.
- This same technique may be used, in reverse, to purposefully access the vascular space.
- most tissues have characteristic electrical properties and virtually any tissue, cavity or space may be accessed through monitoring for this signal during instrument insertion. This is just one embodiment and the access device may be used to access any body tissue, space, or cavity and may do so with feedback from any of the sensors detailed above or any other sensing technology.
- FIGS. 10 A- 10 E are side views of the sensor incorporated into removable insertion trocar.
- the sensor is not incorporated into the catheter itself, but is instead coupled with an insertion tool, in this case a central insertion trocar 107 .
- an insertion tool in this case a central insertion trocar 107 .
- FIGS. 11 A- 11 E illustrate side views of the sensor 118 incorporated into removable sheath 119 .
- the sheath sensor 118 reports entry into the space then the access instrument 1110 is left in the cavity 1111 while the insertion sheath 119 is removed.
- This embodiment is particularly appealing in instance where, once access is confirmed, future confirmation is not required since the sensor is removed along with the sheath.
- This embodiment is most useful, then, in instances where the instrument 1110 will remain in place for a long period of time (i.e. an implantable device with long-term action) or where the desired profile of the instrument 1110 is sufficiently small that inclusion of the sensor 118 into the instrument 1110 itself becomes technically challenging and economically impractical.
- FIGS. 12 A- 12 C demonstrate side views of the External Reader attached to the access device.
- the external reader 1212 may have a display 1213 or some other form of alert to let the user know that the access device has entered the correct cavity, or in which cavity the sensor currently resides.
- the sensor will provide information related to the tissue surrounding the sensor continuously and in real-time so that informed decisions to advance or retract the access device may be made.
- This illustration depicts the sensor incorporated within a removable insertion trocar, but it is important to note that this external reader and any other method of reporting device position to the user may be used with any of the sensing technologies described in this text or illustrated in these drawings.
- FIGS. 13 A- 13 D illustrate side-views of the continuous reader incorporated into access device.
- the integrated reader 1314 may have a display 1315 or some other form of alert to let the user know that the access device has entered the correct cavity, or in which cavity the sensor currently resides.
- the sensor will provide information related to the tissue surrounding the sensor continuously and in real-time so that informed decisions to advance or retract the access device may be made.
- This illustration depicts the sensor incorporated within a removable insertion trocar, but it ⁇ is important to note that this external reader and any other method of reporting device position to the user may be used with any of the sensing technologies described in this text or illustrated in these drawings.
- the sensing device here shown as the insertion trocar
- the sensing device may be disposable or reusable.
- FIGS. 14 A- 14 D illustrate side-views of the intermittent reader incorporated in.to the access device.
- the integrated reader may have a display or some other form of alert to let the user know that the access device has entered the correct cavity, or in which cavity the sensor currently resides.
- the sensor will provide information related to the tissue surrounding the sensor, but will do so only when activated, in this instance via deployment of a reversible a push-button 1416 at the end of the insertion device. This intermittent reading may give exact tissue location information, as well, and may be deployed repeatedly.
- This embodiment is particularly appealing for sensing technologies, ie optical, that may produce heat or other potentially harmful byproducts and should, ideally, only be activated for brief periods of time. As with other embodiments, informed decisions to the advancement or retraction of the access device may be made.
- This illustration depicts the sensor incorporated within a removable insertion trocar, but it is important to note that this external reader and any other method of reporting device position to the user may be used with any of the sensing technologies described in this text or illustrated in these drawings.
- the sensing device here shown as the insertion trocar
- the insertion trocar may be disposable or reusable.
- FIGS. 15 A- 15 E illustrate side-views of the sensor incorporated into a catheter, this time again with the central trocar embodiment.
- a sensor may be incorporated into the external sheath surrounding an insertion trocar.
- the insertion trocar may be removed and the sensor-containing sheath 1517 may remain within the cavity.
- catheter position may be continuously or intermittently assessed while it is advanced thereby ensuring that the catheter is not only in position when the trocar is removed, but that it remains within the correct cavity while it is advanced.
- the catheter or sheath may be single or multiple lumen catheter and may employ a sensor incorporated into instrument or an external sensor.
- the catheter may also use additional sensors or lumens or other communication means to external sensors in order to provide the desire intervention or therapy.
- One preferred embodiment of this device describes a method of accessing the peritoneal cavity with a catheter.
- the sensor-containing catheter may be advanced using the central trocar as a stiffening element. This insertion procedure may employ a blunt dissecting instrument or may utilize the Seldinger technique (or modification thereof).
- the sensor at the tip may report position to the user, either intermittently or—ideally—continuously, indicating which tissues are surrounding the sensor.
- the reader either external or integrated within the access device, reports that the cavity has been accessed via visual, auditory or tactile stimuli.
- the central trocar may then be removed and the catheter advanced, once again during continuous monitoring by the sensor in its optimal embodiment. If the catheter moves from the peritoneal cavity (ie into subcutaneous tissues, muscle, bowel or any other organ) or becomes surrounded by another fluid (blood, urine, etc.) then the sensor may report the change and indicate to the user that the device is no longer optimally placed and that further intervention (whether it be simply adjusting the catheter or performing further investigation) is required.
- the user may ensure precise and consistent access to the peritoneal cavity not only upon insertion but for the duration of the placement of the device and through any required manipulations.
- FIG. 16 details the embodiment wherein intravenous fluid delivery may be automated, or manually adjusted, based on feedback from one or more sensors.
- the infusion catheter 1618 may preferably have a sensor to aid in insertion, but this is not necessary for this invention.
- the infusion catheter also is used to detect the parameters used to optimize therapy, namely electrocardiograph monitoring, electroencephalograph monitoring, pulse oximetry (either internally or peripherally), blood pressure, central venous pressure, cardiac output, cardiac stroke volume, cardiac rate, blood flow (i.e. in superior mesenteric, celiac, renal or other arteries), total circulating blood volume, pressure in veins (particularly those that empty, into the IVC, i.e.
- femoral vein a peripherally inserted central catheter (PICC) 1619 , or bladder catheter 1620 , or additional sensors on this infusion catheter may be used to monitor these, or other, parameters, though to optimize the infusion rate and achieve euvolemia without fluid overload or dehydration.
- PICC peripherally inserted central catheter
- This information may then be transmitted to a central controller 1621 , which integrates all of this information to determine the flow of intravenous fluid.
- This may be used to achieve or maintain euvolemia (ie in sepsis, hemorrhagic shock, etc.) or to maximize infusion for delivery of a therapeutic agent, i.e. chilled fluid and/or solids to achieve hypothermia.
- the sensor or sensors whether cables/catheters or percutaneous monitoring technologies—wired or wireless, may also be disparate from the infusion line so long as the information from this sensor or sensors is transferred to the control unit in order to optimize fluid flow.
- the device of the current invention may or may not incorporate the access sensor, but may utilize sensors to optimize therapy.
- a peripheral venous, central venous or arterial catheter that is capable of maintaining hydration without causing fluid overload.
- Said catheter may incorporate a sensor which may detect central venous pressure, total circulating blood volume, peripheral venous pressure, cardiac output or osmolarity, and/or solute concentrations (ie chloride, sodium, etc.) in order to prevent fluid overload.
- the sensor may also be external to said catheter, so long as the output of said sensor is capable of controlling fluid flow through the catheter.
- said fluid flow is controlled by the output of said sensor which is integrated by a fluid flow control unit which alters the rate of fluid flow based on this output.
- This embodiment may allow the user to bolus large volumes of fluids or solids into the vascular space in order to rehydrate, induce hypothermia or induce hypothermia, or deliver a therapeutic agent or maintain blood pressure in sepsis.
- this technology may provide a fully automated mechanism to optimize fluid flow into the vessel without fluid overloading the patient. Without this automated fluid delivery coupled to hemodynamic parameter monitoring, the patient is in danger of dehydration or fluid overload from any vascular infusion.
- This technology may also be applied to liquid or solid infusion into any body cavity or space in so long as the fluid flow is automated based on feedback from sensors within the body (ideally incorporated into the catheter itself) in order to optimize the volume of infusion.
- This device and method of automating fluid flow based on hemodynamic sensor-based feedback may also be used to generate intravenous hypothermia.
- IV hypothermia induction is limited due to concerns of fluid overload.
- the hemodynamic parameters of the patient can be measured and fluid flow directly or indirectly controlled based on the output of these measurements, the volume of fluid can be maximized while ensuring hemodynamic instability.
- the sensor may be, ideally, incorporated within the catheter and fluid flow into the vasculature may be tailored based on central venous pressure, total circulating blood volume, peripheral venous pressure, cardiac output or osmolarity, and/or solute .concentrations (ie chloride, sodium, etc.) in order to prevent fluid overload.
- the fluid infusion catheter also may function as a thermodilution cardiac output sensor such that the same fluid that is used to generate hypothermia may also be used to detect cardiac output. This information may then be relayed, either directly or indirectly, back to the fluid infusion controller to increase, decrease or even halt fluid flow based on these parameters, ie if cardiac output is low and venous pressure or total circulating volume is low, the patient has a low circulating volume and large volumes of fluid may be safely delivered. If the cardiac output is normal, fluid may also be safely delivered, but the cardiac output must be monitored to ensure that it does not begin to decrease (an indication of fluid overload).
- This same system may be used to infuse normal fluids or hypothermic fluids to sepsis patients or patients requiring intensive maintenance of their hemodynamic status. Sepsis patients that are aggressively monitored do much better than those that are not. This is very nurse-intensive, though, so a system that provides automated optimal fluid infusion based on sensed parameters to ensure that fluid overload does not occur and that fluid infusion is not insufficient.
- This device providing for the automated sensor-based input to control fluid flow and method of delivering fluid using this system may be applicable to a wide range of conditions and should not be limited to the narrow scope of the conditions requiring fluid infusion described here.
- this same procedure and method may be used to access any body cavity, tissue or space reliably and consistently with confidence.
- clinician's may be confident that their instrument resides in its desired space without the requirement for complex instrumentation or costly imaging techniques.
- this method and device may be used in conjunction with any access device that currently requires imaging to confirm placement, but without the need for ionizing radiation. Examples of such devices include nasogastric tubes, central venous lines, chest tubes, feeding tubes, etc.
- Communications between the sensor and display or instrument control unit may also be done wirelessly, ie via RFID or Bluetooth.
- one lumen may be used for fluid delivery while the other may be used for fluid return and a temperature and/or pressure sensor may be incorporated along its length, ideally closer to the fluid return tubing than the fluid delivery tubing.
- the logic controller of the present invention may provide improved safety by monitoring for any of the deleterious changes expected with excess fluid flow i.e. into the peritoneal cavity or vascular space.
- monitored parameters that may signal a warning or automatically result in an adjustment to rate of fluid infusion/extraction and/or fluid temperature include: electrocardiograph monitoring, electro-encephalograph monitoring, pulse oximetry (either internally or peripherally), peritoneal cavity compliance, intrathoracic pressure, intraperitoneal pressure, bladder pressure, rectal pressure, cardiac output, cardiac stroke volume, cardiac rate, blood flow (i.e. in superior mesenteric, celiac, renal or other arteries), pressure in veins (particularly those that empty into the IVC, i.e.
- the invention may be used with any instrument that demands precise access to tissues, body cavities or spaces and/or requires automated, sensor-based intervention or therapy.
Abstract
An automated therapy system having an infusion catheter; a sensor adapted to sense a patient parameter; and a controller communicating with the sensor and programmed to control flow output from the infusion catheter into a patient based on the patient parameter without removing fluid from the patient. The invention also includes a method of controlling infusion of a fluid to a patient. The method includes the following steps: monitoring a patient parameter with a sensor to generate a sensor signal; providing the sensor signal to a controller; and adjusting fluid flow to the patient based on the sensor signal without removing fluid from the patient.
Description
- This application is a continuation of U.S. application Ser. No. 15/993,483 filed May 30, 2018, which is a continuation of U.S. application Ser. No. 15/013,813 filed Feb. 2, 2016, which is a continuation of U.S. application Ser. No. 13/937,102 filed Jul. 8, 2013 (now abandoned), which is a continuation of U.S. application Ser. No. 13/354,210 filed Jan. 19, 2012 (now U.S. Pat. No. 8,480,648), which is a continuation of U.S. application Ser. No. 12/098,365 filed Apr. 4, 2008 (now U.S. Pat. No. 8,100,880), which claims the benefit of U.S. Provisional Application No. 60/921,974 filed Apr. 5, 2007 to Burnett, entitled “Safety Access Device, Fluid Output Monitor & Peritoneal Organ Preservation”, all disclosures of which are incorporated by reference herein in their entirety.
- The present invention relates to the field of medical devices, in particular devices capable safely accessing bodily spaces or cavities.
- All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
- Fluids and other substances are infused into patients for a variety of reasons. For example, fluids may be given to a patient intravenously to hydrate the patient or to control overall blood volume.
- It is often important to control infusion of fluid into patients in order to optimize the therapy being provided. Monitoring of patient parameters can consume precious health care time and resources, however. Fluid infusion into patients is therefore not always optimized.
- Mantle US 2006/0161107 describes a system that extracts fluid from a body cavity, processes the fluid and then recirculates fluid back into the cavity. Mantle does not describe infusion of a fluid into a patient without extraction of the fluid from the patient, however. In addition, the parameters on which the Mantle system is controlled are limited.
- One aspect of the invention provides an automated therapy system having an infusion catheter; a sensor adapted to sense a patient parameter; and a controller communicating with the sensor and programmed to control flow output from the infusion catheter into a patient based on the patient parameter without removing fluid from the patient. In some embodiments, the sensor may be incorporated into the catheter, and in other embodiments, the sensor may be separate from the catheter. The sensor may be, e.g., an ECG sensor; an EEG sensor; a pulse oximetry sensor; a blood pressure sensor; a cardiac output sensor; a thermodilution cardiac output sensor; a cardiac stroke volume sensor; a heart rate sensor; a blood flow sensor; a pH sensor; a blood pO2 sensor; an intracranial pressure sensor; and/or a solute sensor.
- In embodiments of the invention, the catheter may be a peripheral venous catheter; a central venous catheter; an arterial catheter; or a peritoneal catheter (possibly incorporating an intraperitoneal pressure sensor).
- Another aspect of the invention provides a method of controlling infusion of a fluid to a patient. The method includes the following steps: monitoring a patient parameter with a sensor to generate a sensor signal; providing the sensor signal to a controller; and adjusting fluid flow to the patient based on the sensor signal without removing fluid from the patient. In some embodiments, the method includes the step of monitoring cardiac output with the sensor and, possibly, adjusting fluid flow to the patient based on cardiac output monitored by the sensor. In embodiments of the invention, the patient parameter includes an electrocardiogram; an electroencephalogram; blood oxygen saturation; blood pressure; cardiac output; cardiac stroke volume; heart rate; blood flow; total circulating blood volume; whole body oxygen consumption; pH; blood pO2; osmolarity; peritoneal cavity compliance; intrathoracic pressure; bladder pressure; and/or rectal pressure.
- In some embodiments, the adjusting step includes the step of adjusting fluid flow to achieve or maintain patient euvolumia; adjusting flow of a therapeutic agent (such as a chilled medium) to the patient; adjusting fluid flow to the patient through a peripheral venous catheter; adjusting fluid flow to the patient through a central venous catheter; adjusting fluid flow to the patient through an arterial catheter; and/or adjusting fluid flow to the patient's peritoneal cavity.
- Yet another aspect of the invention provides a method of treating hypotension in a patient. The method includes the following steps: monitoring a patient parameter (such as blood pressure or cardiac output) with a sensor to generate a sensor signal; providing the sensor signal to a controller; and adjusting fluid flow to the patient based on the sensor signal without removing fluid from the patient.
- Still another aspect of the invention provides a method of treating sepsis in a patient. The method includes the following steps: monitoring a patient parameter (such as blood pressure, central venous pressure, or cardiac output) with a sensor to generate a sensor signal; providing the sensor signal to a controller; and adjusting fluid flow to the patient based on the sensor signal without removing fluid from the patient. Prevention of hypotension and/or hypovolemia is critical in the care of patients that have suffered severe hemorrhage or are septic. These patients are very difficult to monitor and treat, taking significant nursing time and still resulting in suboptimal therapy due to the intermittent nature of the blood pressure, central venous pressure and/or cardiac output checks. The present invention, then, will optimize fluid flow to the patient while also freeing up the already over-taxed nursing staff for other duties.
- Yet another aspect of the invention provides a method of inducing and reversing therapeutic hypothermia in a patient. The method includes the steps of: monitoring intracranial pressure to generate a sensor signal; providing the sensor signal to a controller; and adjusting rate of hypothermia induction or rewarming based on intracranial pressure (such as by adjusting fluid flow to the patient), or depth of hypothermia, based on the sensor signal.
- In some embodiments of the invention, irrigation and/or lavage of bodily tissues, cavities or spaces (or other patient interventions) may be optimized using a sensor or sensors to report electrical, chemical, acoustic, mechanical properties, pressure, temperature, pH or other parameters surrounding the access device in order to automate and optimize the irrigation/lavage.
- Embodiments of the invention include a peritoneal catheter containing one or more sensors which may detect changes in electrocardiograph monitoring, electroencephalograph monitoring, pulse oximetry (either internally or peripherally), peritoneal cavity compliance, intrathoracic pressure, intraperitoneal pressure, intraperitoneal pressure waveforms, bladder pressure, rectal pressure, cardiac output, cardiac stroke volume, cardiac rate, blood flow (e.g., in superior mesenteric, celiac, renal or other arteries), pressure in veins (particularly the inferior vena cava or those that empty into the inferior vena cava, e.g., femoral vein), pressure in arteries (particularly those distal to the aorta, e.g., the femoral artery), total circulating blood volume, blood oxygenation (e.g., in rectal mucosa, peripheral fingers and toes, etc.), whole body oxygen consumption, pH and/or arterial pO2 (or any other parameter that shows a measurable change with increased peritoneal pressure) to ensure safety of automated or manual peritoneal lavage. The invention also includes methods of performing peritoneal lavage using such devices.
- Embodiments of the invention include an intravascular catheter containing one or more sensors which may detect changes in electrocardiograph monitoring, electroencephalograph monitoring, pulse oximetry (either internally or peripherally), partial pressure of oxygen or CO2, pH, temperature, blood pressure, central venous pressure, cardiac output, cardiac stroke volume, cardiac rate, blood flow (e.g., in superior mesenteric, celiac, renal or other arteries), total circulating blood volume, pressure in veins (particularly those that empty into the inferior vena cava, e.g., femoral vein), pressure in arteries (particularly those distal to the aorta, e.g., the femoral artery), blood oxygenation (e.g., in rectal mucosa, peripheral fingers and toes, etc.), whole body oxygen consumption, pH and/or arterial pO2 (or any other parameter that shows a measurable change with intravascular volume overload) to ensure safety of manual or automated intravascular infusion. The invention also includes methods of using such devices.
- Other embodiments of the invention include control of the rate of infusion to minimize negative effects observed by the sensors. The invention may be used to induce and/or maintain hypothermia or hyperthermia; maximize hydration and/or intravascular volume in a patient receiving intravenous fluids (such as, e.g., post-operative patients, post-hemorrhage patients, septic patients or other intensive care patients).
- Disclosed is a method and device for detection of intake and/or output in an individual. Fluid detection may be fully automated and the user may be alerted if volumes become too low or too high. The data may also be automatically routed to a centralized data collection server so that it may be collected and accessed without the requirement for nursing or other healthcare personnel to record the information manually. The output receptacle, in particular, may contain wireless technology, ie RFID, as well to optimize data collection and reduce nursing burden.
- In reviewing the obstacles of urine output monitoring and data collection, then, it becomes clear that what is needed for widespread adoption is an easily implemented system capable of accurately measuring urine output wherein the use of the device reduces the nursing burden while reporting any issues with urine output in a timely manner. The present invention may also measure and report bladder temperature in real-time and this information may be used to alert the healthcare providers of changes in therapy and/or may be used to control and direct depth of therapeutic hypothermia. The reservoir/receptacle may also contain sensors capable of detecting other materials of interest within the fluid including, but not limited to: hemoglobin, blood, bacteria, leukocyte esterase, glucose, protein, particulate matter, etc. This information may also trigger an alert to provide real-time data monitoring of these parameters. Additionally, the present invention anticipates the use of wired or, ideally, wireless transmission of data to allow for centralized collection of data and centralized reporting. This is, once again, useful in reducing healthcare provider burden by allowing fewer personnel to monitor the data from all of the patients utilizing said system.
- In addition, the system of the present invention anticipates the use of RFID technology within or attached to the reservoir itself which may be remotely queried and interrogated by one or more RFID readers. The data collected may be encrypted and specific to each receptacle such that the up.ne output reported may be securely associated with an individual patient. In its optimal embodiment, the reservoir may contain conducting channels connected to the RFID circuitry which determine the urine level by detection of the level of a simple short-circuit through the conducting fluid itself which may then be reported by the RFID chip to the reader. This cheap, easy-to-use system overcomes the obstacles of previous attempts to automate urine output monitoring.
- In addition, information collected using the present invention may be used to automatically adjust therapeutic hypothermia, delivery of medicine or other interventions.
- Disclosed is a method and device for safe access of a bodily tissues, spaces or cavities and automated therapy. The improved safety of the current invention is based, in part, on the ability of the access system to report entrance into the tissue/space/cavity via an integrated sensor. In its preferred embodiment, additional sensing capabilities may be incorporated, as well, to optimize the automated therapy delivered or intervention required.
- In reviewing the obstacles of providing safe access to bodily cavities and spaces, it becomes clear that over- and under-insertion of invasive instrumentation is a major issue. During catheter placement in major vessels, for example, many of the complications that occur are due to over-insertion of the insertion needle or sliding of the catheter over the needle at a point when the needle is not appropriately positioned. The disclosed invention, then, is a method and device for safe access of a bodily tissues, spaces or cavities. The improved safety of the current invention is based, in part, on the ability of the access system to report entrance into the tissue, space, or cavity via a sensor integrated within, or inserted simultaneously with, the instrument itself. In its preferred embodiment, additional sensing capabilities may be incorporated, as well, to optimize the desired intervention or therapy to be delivered.
- 1) A device for accessing bodily tissues, spaces or cavities outside of the respiratory tree wherein; said access device or its insertion instrumentation incorporates a sensor and wherein said sensor may report access to the desired tissues, spaces or cavities
- 2) The device of 1 wherein said sensor is capable of sensing optical, electrical, chemical, acoustic and/or mechanical properties to differentiate between tissues, spaces or cavities and indicate when said device is in the desired location
- 3) The device of 1 wherein said access device may incorporate additional sensors in order to optimize therapy provided by said device
- 4) The device of 2 wherein said access device sensor may report entrance into a cavity and wherein said additional sensor (or sensors) may report pressure, temperature, pH or other parameters in order to optimize therapy
- 5) The device of 2 wherein said cavity to be accessed may be the peritoneal cavity, and wherein said sensor may directly or indirectly detect entry into this cavity.
- 6) The device of 4 wherein said additional sensors may directly or indirectly detect mechanical properties (such as pressure), chemical composition, thermal properties, electrical properties, acoustic properties or optical ⋅ properties to optimize filling of the peritoneal cavity with gases, liquids and/or solids.
- 7) The device of 2 wherein said cavity to be accessed may include peritoneal, pleural, cerebrospinal, biliary, gastrointestinal, gastric, intestinal, urinary cavities, or pathologic tissues, and wherein said sensor may directly or indirectly detect entry into this cavity.
- 8) The device of 2 wherein said space to be accessed may include the cardiovascular, venous, arterial, lymphatic, ureteral cerebrospinal ventricular spaces, or pathologic spaces and wherein said sensor may directly or indirectly detect entry into this space.
- 9) The device of 2 wherein said tissues to be accessed may include lung, liver, heart, bladder, brain, intestinal, pancreatic, splenic, vascular tissues, or pathologic spaces and wherein said sensor may directly or indirectly detect entry into these tissues.
- 10) The device of 1 wherein said sensor is incorporated into the device itself.
- 11) The device of 1 wherein said sensor is incorporated into the instrumentation required to insert said access device.
- 12) The device of 1 wherein said sensor may be introduced along with said access device and may be reversibly attached or contained within said device.
- 13) The device of 1 wherein said sensor may be physically connected to an external display.
- 14) The device of 1 wherein said sensor may be wirelessly connected to an external display.
- 15) The device of 13 wherein said display may be incorporated into said access device
- 16) The device of 13 wherein said display may be reversibly or irreversibly attached to an external display
- 17) The device of 14 wherein said display may be incorporated into said access device
- 18) The device of 1 wherein said sensor may be intermittently activated to detect the tissues surrounding the sensor
- 19) The device of 18 wherein said sensor may be repeatedly activated to detect the tissues surrounding the sensor
- 20) The device of 1 wherein said sensor continuously detects which tissues surround the sensor
- 21) The device of 2 wherein said sensor detects optical transfer of wavelengths from a transmitter to a, receiver and wherein the wavelength conduction path includes the sensor incorporated within said device
- 22) The device of 2 wherein said sensor detects electrical properties surrounding said sensor to detect unique electrical signatures of the surrounding tissues
- 23) The device of 2 wherein said sensor detects chemical properties (ie albumin, pH, etc.) surrounding said sensor to detect unique chemical components, or concentrations of components, within the tissues/spaces
- 24) The device of 2 wherein said sensor detects acoustic properties of the surrounding tissues/spaces to detect entrance into the desired tissue/space
- 25) The device of 2 wherein said sensor detects mechanical properties (such as pressure, shear forces, etc.) surrounding said sensor to detect entrance into desired tissue/space
- 26) The device of 2 wherein multiple sensors of any type are used to indicate exact positioning and the composition of the fluid surrounding said device
- 27) The device of 26 wherein one or more sensors positively predict tissue/space access while one or more sensors negatively predict tissue/space access
- 28) The device of 26 wherein one or more sensors positively predict tissue/space access while one or more sensors detect potential complicating factors, ie the presence of unexpected blood, etc.
- 29) The device of 3 wherein irrigation and/or lavage of bodily tissues, cavities or spaces is optimized by said additional sensors and wherein said access device contains a sensor to detect pressure, temperature, or other parameters to optimize the irrigation/lavage.
- 30) A method for accessing bodily tissues, spaces or cavities wherein; an access device or its insertion instrumentation incorporates a sensor and wherein said sensor may report access to the desired tissues, spaces or cavities
- 31) The method of 30 wherein said sensor is capable of sensing optical, electrical, chemical, acoustic and/or mechanical properties to differentiate between tissues, spaces or cavities and indicate when said device is in the desired location
- 32) The method of 30 wherein said access device may incorporate additional sensors in order to optimize therapy provided by said device
- 33) The method of 31 wherein said access device sensor may report entrance into a cavity and wherein said additional sensor (or sensors) may report electrical, chemical, acoustic, mechanical properties, pressure, temperature, pH or other parameters in order to optimize therapy
- 34) The method of 31 wherein said cavity to be accessed may be the peritoneal cavity, and wherein said sensor may directly or indirectly detect entry into this cavity
- 35) The method of 33 wherein said additional sensors may directly or indirectly detect mechanical properties (such as pressure), chemical composition, electrical properties, acoustic properties or optical properties to optimize filling of the peritoneal cavity with gases, liquids and/or solids.
- 36) The method of 31 wherein said cavity to be accessed may include peritoneal, pleural, cerebrospinal, biliary, gastrointestinal, gastric, intestinal, urinary cavities, or pathologic spaces and wherein said sensor may directly or indirectly detect entry into one or more of these cavities.
- 37) The method of 31 wherein said space to be accessed may include the cardiovascular, venous, arterial, lymphatic, ureteral cerebrospinal ventricular spaces, or pathologic spaces and wherein said sensor may directly or indirectly detect entry into one or more of these spaces.
- 38) The method of 31 wherein said tissues to be accessed may include lung, liver, heart, bladder, brain, intestinal, pancreatic, splenic, vascular tissues, or pathologic spaces and wherein said sensor may directly or indirectly detect entry into one or more of these tissues.
- 39) The method of 30 wherein said sensor is incorporated into the device itself.
- 40) The method of 30 wherein said sensor is incorporated into the instrumentation required to insert said access device.
- 41) The method of 30 wherein said sensor may be introduced along with said access device and may be reversibly attached or contained within said device.
- 42) The method of 30 wherein said sensor may be physically connected to an external display.
- 43) The method of 30 wherein said sensor may be wirelessly connected to an external display.
- 44) The method of 42 wherein said display may be incorporated into said access device
- 45) The method of 42 wherein said display may be reversibly or irreversibly attached to an external display
- 46) The method of 43 wherein said display may be incorporated into said access device
- 47) The method of 30 wherein said sensor may be intermittently activated to detect the tissues surrounding the sensor
- 48) The method of 47 wherein said sensor may be repeatedly activated to detect the tissues surrounding the sensor
- 49) The method of 30 wherein said sensor continuously detects which tissues surround the sensor
- 50) The method of 31 wherein said sensor may detect optical transfer of wavelengths from a transmitter to a receiver and wherein the location of said device may be determined based on absorption or transmission of said wavelengths
- 51) The method of 31 wherein said sensor detects electrical properties surrounding said sensor to detect and report unique electrical signatures of the surrounding tissues and allow for avoidance of undesirable tissues/spaces including conductance, impedance, resistance, capacitance, etc.
- 52) The method of 31 wherein said sensor detects chemical properties (ie albumin, pH, etc.) surrounding said sensor to detect unique chemical components, or concentrations of components, within the tissues/spaces and avoidance of undesirable tissues/spaces
- 53) The method of 31 wherein said sensor detects acoustic properties of the surrounding tissues/spaces to detect entrance into the desired tissue/space and/or avoidance of undesirable tissues/spaces
- 54) The method of 31 wherein said sensor detects mechanical properties (such as pressure, shear forces, etc.) surrounding said sensor to detect entrance into desired tissue/space and/or avoidance of undesirable tissues/spaces
- 55) The method of 31 wherein said sensor detects thermal properties of the surrounding tissues/spaces to detect entrance into the desired tissue/space and/or avoidance of undesirable tissues/spaces
- 55) The method of 31 wherein multiple sensors of any type may be used to indicate exact positioning and the composition of the fluid surrounding said device
- 56) The method of 55 wherein one or more sensors may be used to positively predict tissue/space access while one or more sensors negatively predict tissue/space access
- 57) The method of 55 wherein one or more sensors may be used to positively predict tissue/space access while one or more sensors detect potential complicating factors, ie the presence of unexpected blood, etc.
- 58) The method of 55 Wherein one or more sensors may be used to provide multiple data points to help determine the exact position of said sensor or sensors.
- 59) The method of 32 wherein irrigation and/or lavage of bodily tissues, cavities or spaces may be optimized by said additional sensors and wherein said access device contains a sensor or sensors to report electrical, chemical, acoustic, mechanical properties, pressure, temperature, pH or other parameters surrounding the access device in order to optimize said irrigation/lavage.
- 59) The method of 32 wherein an intervention performed in said tissues, cavities or spaces may be optimized by said additional sensors and wherein said access device contains a sensor or sensors to report electrical, chemical, acoustic, mechanical properties, pressure, temperature, pH or other parameters surrounding the access device in order to optimize said intervention.
- 60) A peritoneal catheter containing one or more sensors which may detect changes in electrocardiograph monitoring, electroencephalograph monitoring, pulse oximetry (either internally or peripherally), peritoneal cavity compliance, intrathoracic pressure, intraperitoneal pressure, bladder pressure, rectal pressure, cardiac output, cardiac stroke volume, cardiac rate, blood flow (i.e. in superior mesenteric, celiac, renal or either arteries), pressure in veins (particularly those that empty into the IVC, i.e. femoral vein), pressure in arteries (particularly those distal to the aorta, i.e. the femoral artery), blood oxygenation (i.e. in rectal mucosa, peripheral fingers and toes, etc.), whole body oxygen consumption, pH and/or arterial p02 (or any other parameter that shows a measurable change with increased peritoneal pressure) to ensure safety of automated or manual peritoneal lavage
- 61) A method of performing peritoneal lavage wherein changes in electrocardiograph monitoring, electroencephalograph monitoring, pulse oximetry (either internally or peripherally), peritoneal cavity compliance, intrathoracic pressure, intraperitoneal pressure, bladder pressure, rectal pressure, cardiac output, cardiac stroke volume, cardiac rate, blood flow (i.e. in superior mesenteric, celiac, renal or other arteries), pressure in veins (particularly those that empty into the IVC, i.e. femoral vein), pressure in arteries (particularly those distal to the aorta, i.e. the femoral artery), blood oxygenation (i.e. in rectal mucosa, peripheral fingers and toes, etc.), whole body oxygen consumption, pH and/or arterial p02 (or any other parameter that shows a measurable change with increased peritoneal pressure) are monitored and may be utilized to ensure safety of automated or manual peritoneal lavage
- 62) An intravascular catheter containing one or more sensors which may detect changes in electrocardiograph monitoring, electroencephalograph monitoring, pulse oximetry (either internally or peripherally), partial pressure of oxygen or C02, pH, temperature, blood pressure, central venous pressure, cardiac output, cardiac stroke volume, cardiac rate, blood flow (i.e. in superior mesenteric, celiac, renal or other arteries), total circulating blood volume, pressure in veins (particularly those that empty into the IVC, i.e. femoral vein), pressure in arteries (particularly those distal to the aorta, i.e. the femoral artery), blood oxygenation (i.e. in rectal mucosa, peripheral fingers and toes, etc.), whole body oxygen consumption, pH and/or arterial p02 (or any other parameter that shows a measurable change with intravascular volume overload) to ensure safety of manual or automated intravascular infusion
- 63) A method of performing intravascular infusion wherein one or more sensors may detect changes in electrocardiograph monitoring, electroencephalograph monitoring, pulse oximetry (either. internally or peripherally), partial pressure of oxygen or C02, pH, temperature, blood pressure, central venous pressure, cardiac output, cardiac stroke volume, cardiac rate, blood flow (i.e. in superior mesenteric, celiac, renal or other arteries), total circulating blood volume, pressure in veins (particularly those that empty into the IVC, i.e. femoral vein), pressure in arteries (particularly those distal to the aorta, i.e. the femoral artery), blood oxygenation (i.e. in rectal mucosa, peripheral fingers and toes, etc.), whole body oxygen consumption, pH and/or arterial p02 (or arty other parameter that shows a measurable change with intravascular volume overload) which may be used to regulate the rate of infusion
- 64) The method of 63 wherein said rate of infusion may be maximized in the absence of negative effects to the monitored parameters
- 65) The method of 63 wherein said rate of infusion may be reduced or halted in the presence of negative effects to the monitored parameters
- 66) The method of 63 wherein said intravascular infusion may be utilized to induce and/or maintain hypothermia or hyperthermia
- 67) The method of 63 wherein said intravascular infusion may be utilized to optimize hydration and/or intravascular volume in any patient receiving intravenous fluids
- 68) The method of 63 wherein said intravascular infusion may be utilized to optimize hydration and/or intravascular volume in post-operative patients
- 69) The method of 63 wherein said intravascular infusion may be utilized to optimize hydration and/or intravascular volume in septic or other intensive care patients
- 70) The method of 63 wherein said intravascular infusion may be utilized to optimize hydration and/or intravascular volume with additional inputs which may include sensor-based urine output detection
- 71) The method of 70 wherein said monitored parameters and urine output information may be used, according to a hydration algorithm, to report issues with intake or output and automatically correct these issues via automated changes to the rate of infusion and/or addition of diuretics
- The novel features of the invention are set forth with particularity in the claims that follow. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:
-
FIG. 1 shows an automated infusion system in which infusion is controlled based on patient parameters sensed by multiple sensors. -
FIG. 2 shows an automated infusion system in which a sensor controlling infusion is separate from the infusion catheter. -
FIG. 3 shows an automated infusion system in which sensing and infusion are performed with the same catheter. -
FIG. 4 —Console with optional sensor lead (may be wireless). -
FIG. 5 —Sensor-based Urine Output Measurement. -
FIG. 6 —Console with automated infusion therapy system. -
FIG. 7 —Volume-sensing Urine Receptacle with Dock. -
FIG. 8 —Volume-sensing Urine Receptacle—RFID Embodiment. -
FIGS. 9A-9D —Side view of the sensor incorporated into the instrument. -
FIGS. 10A-10E —Side view of the sensor incorporated into removable insertion trocar. -
FIGS. 11A-11E —Side view of the sensor Incorporated into removable sheath. -
FIGS. 12A-12C —Side view of the External Reader attached to Access Device. -
FIGS. 13A-13D —Side view of the continuous reader incorporated into Access Device (trocar embodiment). -
FIGS. 14A-14D —Side view of the intermittent reader incorporated into Access Device (trocar embodiment). -
FIGS. 15A-15E —Side view of the sensor incorporated into access device (shown as catheter with insertion trocar). -
FIG. 16 —Intravenous fluid flow automated by sensors. -
FIGS. 1-3 show embodiments of the invention wherein intravenous fluid delivery may be automated, or manually adjusted, based on feedback from one or more sensors. In these embodiments, the infusion catheter may have a sensor to aid in insertion, but this is not necessary for this invention. - In one embodiment, the infusion catheter also is used to detect the parameters used to optimize therapy.
FIG. 1 shows an infusion system with aninfusion controller 10 operably connected to anintravenous infusion catheter 12 via aninfusion line 14.Infusion catheter 12 also has a sensor (not shown) attached to or associated with it to monitor a patient parameter. The sensor also communicates withcontroller 10 either throughline 14 or via some other communication channel. Suitable patient parameters include electrocardiograph monitoring, electroencephalograph monitoring, pulse oximetry (either internally or peripherally), blood pressure, central venous pressure, cardiac output, cardiac stroke volume, cardiac rate, blood flow (e.g., in superior mesenteric, celiac, renal or other arteries), total circulating blood volume, pressure in veins (particularly those that empty into the inferior vena cava, e.g., femoral vein), pressure in arteries (particularly those distal to the aorta, e.g., the femoral artery), blood oxygenation (e.g., in rectal mucosa, peripheral fingers and toes, etc.), whole body oxygen consumption, pH, arterial pO2, or any other parameter that shows a measurable change with intravascular volume overload. - As shown in
FIG. 1 , additional catheters, here envisioned as a peripherally inserted central catheter (PICC) 16 and/or aperitoneal catheter 18, or additional sensors oninfusion catheter 12 may be used to monitor these or other parameters, and to optimize the infusion rate and achieve euvolemia without fluid overload or dehydration. Flow of fluid and/or a fluid/solid mixture (e.g., an ice slurry) tocatheters 16 and/or 18 is controlled bycontroller 10 throughlines central controller 10, which integrates all of this information to determine the flow of intravenous fluid throughcatheter 12 and/orcatheter 16 and flow of peritoneal fluid throughcatheter 18. This information may be used to achieve or maintain euvolemia (e.g., in sepsis, hemorrhagic shock, etc.) or to maximize infusion for delivery of a therapeutic agent, e.g., chilled fluid and/or solids to achieve hypothermia. Alternatively,catheters catheter 16 orcatheter 18. In yet further embodiments, the depth of hypothermia and/or rate of hypothermia induction or rewarming may be tailored based on intracranial pressure sensor(s) (not shown) communicating withcontroller 10 viacommunication line 35. This system and method may be used with any method of inducing hypothermia (e.g., cooling blankets, intravascular catheters, intravenous fluid infusion, peritoneal lavage, etc.) so long as the change in temperature, particularly rewarming, is controlled at least in part by an intracranial pressure sensor. - The sensor or sensors, whether cables/catheters or percutaneous monitoring technologies, and whether wired or wireless, may also be separate from the infusion line so long as the information from this sensor or sensors is transferred to the control unit in order to optimize fluid flow. Thus, as shown in
FIG. 2 , the patient parameter sensor may be associated with PICC 24 and communicate with controller vialine 26, and infusion to the patient may be via line 22 andinfusion catheter 20, as controlled bycontroller 10. In some embodiments, of course, sensing and infusion may be performed through a single catheter, such asPICC 30, and controlled bycontroller 10 throughlines FIG. 3 . In some embodiments, the infusion and monitoring device of the current invention may incorporate an access sensor, such as that described in a commonly owned patent application, U.S. patent application Ser. No. 12/098,355, filed Apr. 4, 2008, titled “Device And Method For Safe Access To A Body Cavity”. - One example of such a device is a peripheral venous, central venous or arterial catheter that is capable of maintaining hydration without causing fluid overload. The catheter may incorporate a sensor that may detect central venous pressure, total circulating blood volume, peripheral venous pressure, cardiac output or osmolarity, and/or solute concentrations (e.g., chloride, sodium, etc.) in order to prevent fluid overload. The sensor may also be external to the catheter, so long as the output of said sensor is capable of controlling fluid flow through the catheter. In this embodiment, fluid flow is controlled by the output of the sensor, which is integrated by a fluid flow control unit which alters the rate of fluid flow based on this output. This embodiment may allow the user to bolus large volumes of fluids or solids into the vascular space in order to rehydrate, induce hypothermia or reverse hypothermia, or deliver a therapeutic agent or maintain blood pressure in sepsis.
- In addition, this technology may provide a fully automated mechanism to optimize fluid flow into the vessel without fluid overloading the patient. Without this automated fluid delivery coupled to hemodynamic parameter monitoring, the patient is in danger of dehydration or fluid overload from infusion of fluid into any body cavity. This technology may also be applied to liquid or solid infusion into any body cavity or space in so long as the fluid flow is automated based on feedback from sensors within the body (possibly incorporated into the catheter itself) in order to optimize the volume of infusion.
- This device and method of automating fluid flow based on hemodynamic sensor-based feedback may also be used to generate intravenous hypothermia. In its current state, IV hypothermia induction is limited due to concerns of fluid overload. If the hemodynamic parameters of the patient can be measured and fluid flow directly or indirectly controlled based on the output of these measurements, the volume of fluid can be maximized while ensuring hemodynamic instability. In this embodiment, the sensor may be incorporated within the catheter, and fluid flow into the vasculature may be tailored based on central venous pressure, total circulating blood volume, peripheral venous pressure, cardiac output or osmolarity, and/or solute concentrations (e.g., chloride, sodium, etc.) in order to prevent fluid overload.
- In one embodiment, the fluid infusion catheter also may function as a thermodilution cardiac output sensor such that the same fluid that is used to generate hypothermia may also be used to detect cardiac output. This information may then be relayed, either directly or indirectly, back to the fluid infusion controller to increase, decrease or even halt fluid flow based on these parameters. For example, if cardiac output is low and venous pressure or total circulating volume is low, the patient has a low circulating volume and large volumes of fluid may be safely delivered. If the cardiac output is normal, fluid may also be safely delivered, but the cardiac output must be monitored to ensure that it does not begin to decrease (an indication of fluid overload). Blood flow, as detected by, for instance, thermodilution may be determined in a peripheral vessel as well. These data, while relatively useless on their own in a clinical setting due to variability in peripheral blood flow, may provide a baseline flow profile which may be rechecked over time in order to compare flow within that individual vessel to the baseline flow. Relatively improved flow may be correlated to improved cardiac output, while a relative reduction in flow may be correlated to fluid overload.
- This same system may be used to infuse normal fluids or hypothermic fluids to sepsis patients or patients requiring intensive maintenance of their hemodynamic status. Sepsis patients that are aggressively monitored do much better than those that are not. Aggressive monitoring is very nurse-intensive, however. A system that provides automated optimal fluid infusion based on sensed parameters to ensure that fluid overload does not occur and that fluid infusion is not insufficient would be an improvement over current methods of treating sepsis patients. The devices and methods for automated sensor-based input to control fluid flow to a patient may be applicable to a wide range of conditions and should not be limited to the narrow scope of the conditions requiring fluid infusion described here.
- The logic controller of the present invention may provide improved safety by monitoring for any of the deleterious changes expected with excess fluid flow, e.g., into the peritoneal cavity or vascular space. Examples of monitored parameters that may signal a warning or automatically result in an adjustment to rate of fluid infusion/extraction and/or fluid temperature include: electrocardiograph monitoring, electroencephalograph monitoring, pulse oximetry (either internally or peripherally), peritoneal cavity compliance, intrathoracic pressure, intraperitoneal pressure, intraperitoneal pressure waveforms, bladder pressure, rectal pressure, cardiac output, cardiac stroke volume, cardiac rate, total circulating blood volume, blood flow (e.g., in superior mesenteric, celiac, renal or other arteries), pressure in veins (particularly those that empty into the IVC, e.g., femoral vein), pressure in arteries (particularly those distal to the aorta, e.g., the femoral artery), blood oxygenation (e.g., in rectal mucosa, peripheral fingers and toes, etc.), whole body oxygen consumption, pH and arterial pO2 and any other parameter that shows a measurable change once the peritoneal or vascular spaces have been overloaded.
- These parameters in particular have been found to change with increases in peritoneal pressure, with significantly negative impact on each parameter found at 40 mmHg. Thus, monitoring for these changes in conjunction with a peritoneal infusion catheter of the present invention will allow for even greater safety with peritoneal infusion. These parameters may be measured a variety of ways and the data transmitted either wirelessly or via wires to the logic controller in order to alert the healthcare provider or to automatically adjust the fluid flow/temperature in order to optimize both the flow of the peritoneal fluid and patient safety.
-
FIG. 4 illustrates a console 40 with optional sensor lead 44 which may or may not be wireless. The console itself may record output/input data 42. This data may be held in memory, printed or directly transmitted to a centralized data collection server. Said console may connect to theurine receptacle 46 to determine urine output either via a wire or wirelessly. -
FIG. 5 illustrates sensor-based Urine Output Measurement. In this instance, the console 50 or RFID reader can trigger alert if urine output is too low or too high over a set period of time. May also have intravenous infusion capabilities to provide input and output data and tailor delivery of fluids and/or medicines (ie diuretics) via an automated system based on the urine output feedback. The device may include an optional Docking Station 54—ideally reusable, may connect to receptacle 52 and transmit data to control unit either via wires or, ideally, wirelessly. May also measure urine level via weight, etc. Optional Urine Level Sensors 56 may report level of urine via conductivity, resistance, impedance, etc. Sensors may also continuously or intermittently detect bacteria, hemoglobin or other substances of interest in urine. Urinary catheter 58 is also shown. -
FIG. 6 illustrates aconsole 60 with automated infusion therapy system. Console may integrate patient data, ie fluids received, urine output recorded, etc. to automate therapy, ie delivery of fluids or LASIX if the pt is dehydrated or fluid overloaded respectively. May also trigger local alert (ie beeping) and centralized alert (ie system alarm) if urine output drops too low. The console may also integrate a fluid infusion or medicine infusion capabilities, ie an IV infusion pump, and may adjust infusion rates based on this data or data acquired from other sensors in an automated fashion. The console may communicate wirelessly, as well, to these and any other sensors within the body.Infusion catheter 62 is also shown—may deliver drugs or fluid based on urine output and other parameters.Urinary catheter 64 is also shown. -
FIG. 7 illustrates a volume-sensing Urine Receptacle with reusable communicating and/or sensing element. Thereceptacle 70 itself may detect urine output based upon level at which sensors are triggered—ie have hash-marks represent electrical contacts and when an electrical path is made between two contacts, and all contacts below, the level can be reported at that level. May be electrical, optical, chemical or mechanical sensors. May also contain diffuse or discrete sensing areas that may detect the presence of absence of certain materials of interest, ie hemoglobin, protein, glucose, bacteria, blood, leukocyte esterase, etc. either intermittently or continuously. May report any and/or all of this information to the console, locally (via beeping, etc.) or centrally via piping data to a central information collection area. Alerts triggered if urine output drops below 30 cc/hr in post-operative setting or any otherwise defined threshold. May also be disposable and connect to thedocking station 72 which may communicate the data from said, receptacle wirelessly. The docking station may be connected anywhere on said receptacle, or optionally, not included at all. If a docking station is used, it may detect urine output based simply upon weight or pressure applied to base. May contain disposable or, ideally, durable optical, electrical or chemical sensors capable of sensing glucose, electrolytes, bacteria, hemoglobin, blood, etc. May interface with specifically designed area of the urine receptacle to allow for this measurement—ie an optically clear window for optical measurement of blood, etc. May also fasten onto the urine receptacle in any position so long as it engages the receptacle. This or the receptacle itself may contain an inductive antenna and/or RFID capabilities to allow for wireless querying and reporting of the level of urine or other fluid collection. -
FIG. 8 illustrates a volume-sensing Urine Receptacle 80 with RFID capabilities. This embodiment may contain RFID circuitry to collect and transmit data directly from within the receptacle to a RFID Reader. When queried by the RFID reader may simply detect impedance, resistance, capacitance or any other electrical or nonelectrical property to detect the urine level and report this back to the reader. Reader may then trigger alert if urine output is high or low. The RFID chip may be capable of detecting changes in optical, chemical, electrical, acoustic or mechanical properties, as well. May be active or passive RFID and may contain antenna in any position and, ideally, may transmit a unique signal to identify the receptacle to the reader and allow multiple receptacles to be queried at once. The RFID chip may incorporate a small battery (to extend its range) in an active RFID embodiment or may be passive in nature and be powered solely by the transmissions from said RFID reader. TheRFID Reader 82 may query device from a distance to wirelessly check the urine output level or may be centralized to query all receptacles within a unit, floor or hospital and issue an alert if urine output drops too low (or is too high). May record urine output, as well, and replace the individual unit consoles illustrated inFIGS. 1-3 . The RFID reader may also report data from other sensors within said system, including bladder temperature or presence of certain materials within the urine, ie blood, hemoglobin, leukocyte esterase, other indicators of bacterial infection, protein, glucose, etc. - In another embodiment, a urinary catheter capable of sensing physiologic parameters is envisioned. Additional sensing capabilities may include: blood pressure, oxygen saturation, pulse oximetry, heart rate, EKG, capillary fill pressure, etc. In particular, the incorporation of pulse oximetry technology to allow for blood oxygen concentration or saturation determination with a urinary catheter is envisioned. This device may function by incorporating pulse oximetry capabilities anywhere along the length of the catheter, but ideally the sensor or sensors will be contained within the tubing of the device to ensure approximation to the urethral mucosa. With this invention, the healthcare provider will be able to decompress the bladder with a urinary catheter and obtain pulse oximetry data in a repeatable and accurate manner. The power source for this device may be incorporated within the urinary drainage bag or within the catheter itself. Ideally, the pulse oximeter will be reusable and the catheter interface will be disposable wherein the pulse oximeter is simply reversibly attached to the disposable catheter and removed once measurements of oxygen are no longer desired. The urinary catheter, then, may contain an optically transparent, or sufficiently transparent, channel for the oximetry signal, ie a fiber-optic cable, transparent window, etc., and an interface for the reusable oximeter and otherwise be a standard urinary catheter. This method and device for urethral pulse oximetry may be used in conjunction with any of the other embodiments detailed herein or may be a stand-alone device in and of itself.
-
-
- I. Device: Automated Urine Output Measurement
- II. Indications for Use (IFU): Any condition requiring urine output monitoring
- III. Preferred Methods for Use:
- a. Upon placement of a Foley catheter, ideally with a temperature sensor or intra-vesicular sensor/probe, the receptacle component of the Automated Urine Output Measurement system is attached to the output tubing
- b. The receptacle is attached to a stationary object, or the patient themselves and the data ID for the receptacle is entered into the RFID reader, which may be centralized and capable of querying all Automated Urine Output Measurement receptacles within a predefined range or area
- c. The RFID reader then queries, and optionally powers, the RFID chip within the receptacle which reports the fluid level based on the impedance, conductance or other electrical properties of sensors within the bag
- d. This data is transmitted to centralized data collection point where it may be monitored by an individual
- e. If certain thresholds are not met, ie 30 cc/hr urine output, local alarms (ie a beeping) or remote alarms (ie an alert at the centralized monitoring station) may be triggered
- f. The information obtained from the receptacle may be used in a feedback loop to automate the delivery and/or extraction of fluids and/or medicines from the patient to optimize therapy
- g. In conjunction with urine output measurement the healthcare professional may also attach an oximeter to a specifically designed site on the urinary catheter in order to obtain pulse oximetry measurements
- h. Once the measurements have been completed, the oximeter may be reused (or disposed of) and the urinary catheter either removed or kept in place
- In its preferred embodiment, the novel access system involves the use of a puncturing instrument in conjunction with a sensor at, or near, the tip of the instrument. This sensor may be capable of detecting changes within its environment in order to report that it has passed from the subcutaneous tissues into the desired cavity, space or tissue. For example, a novel peritoneal access catheter is envisioned which is capable of detecting differences between the vascular, extraperitoneal, intestinal and intraperitoneal spaces. This sensor may detect I) changes in the physical properties surrounding the instrument such as pressure, acceleration, forces or other physical properties, 2) chemical changes surrounding the instrument, ie the presence or absence of compounds such as albumin, hemoglobin, glucose or the pH or other chemical properties, or 3) changes in the electrical properties such as conductance, resistance, impedance, capacitance, etc. of the tissues 4) changes in the acoustic or vibratory properties of the tissues, 5) changes in optical properties such as refraction of light within the tissue, or 6) changes in any other parameter that is able to be sensed via a sensor placed on, in, within or otherwise attached to or in communication with said instrument.
- In any of the embodiments, as well, the sensing element of said device may be incorporated in instrument itself, may be introduced along with the instrument or may be external to the instrument and communicate through a channel in said instrument. In the ideal embodiment, the sensor is incorporated into either in the instrument or its introducer and is able to provide immediate, definitive feedback that the correct body cavity has been accessed. For example, the electrical properties of blood are different from that of air, the epidermis, the subcutaneous space, the fascia and the adventia of the vessel. Thus, in accessing the femoral artery, for instance, one can slowly insert the arterial access device (ie a catheter with a sharp insertion trocar/needle) which incorporates a sensor in the catheter or insertion trocar/needle (in this case electrical) which will immediately report a change in the sensed parameter (in this case inductance, resistance, capacitance, etc.) indicating that the vessel has been entered. This same reading can then them be monitored continuously as the instrument is manipulated (ie the catheter is slid over the trocar/needle into the vessel) to ensure that the instrument does not migrate during manipulation and remains within the desired space.
- Another embodiment comprises the use of heat differentials to guide a catheter/needle to the appropriate space/tissue. For example, by placing a cold pack on the skin over the femoral artery, a temperature differential will exist with the warmest location being in the intravascular space. A temperature sensing catheter can be guided to the warmest location which would be inside the vessel.
- This sensing technique may be employed with virtually any invasive instrument to ensure correct placement via detection of changes in any of the aforementioned parameters (i.e. physical, chemical, thermal, electrical, acoustic/vibratory, optical or other parameter capable of being sensed) with the only requirement being that the target tissue or space within the body must have a sufficiently distinct sensor reading that it may be distinguished from its surrounding tissues. These invasive instruments may include, but are not limited to instruments, catheters or devices intended to access the following spaces/tissue: peritoneal cavity or fluid (ie paracentesis or peritoneal lavage), vascular fluid or space (arterial catheter, intravenous catheter, etc.), cerebrospinal fluid or space, pleural or pulmonary fluid or space (ie chest tubes), pericardial or cardiac space or tissue, urologic fluid or space (ie suprapubic catheters), gynecologic access (ie fallopian tubes or ovaries), gastrointestinal fluid or space (ie nasogastrostomy or gastrostomy tubes), ocular or bulbar tissues or spaces, neurological tissue or space (ie brain biopsy instruments), pathological tissue or space (ie abscess, hematoma, cyst, pseudocyst), bone marrow tissue or space, or any other tissues or spaces that may be accessed minimally invasively, percutaneously or through a natural orifice.
- The sensing element may be disposable or reusable. The sensing element may be incorporated reversibly or irreversibly into the instrument itself, into the instrument's sheath, into the instrument's trocar, or kept external to said instrument with movement of gases, fluids or solids down the length of the instrument to the externally located sensor continuously or upon activation. Said sensor may also communicate wirelessly from the instrument to an external receiver removing the requirement for a tethering cord and allowing for a disposable and reusable component. The controller/reader may alert the user that access has been obtained through tactile, auditory, visual or any other _stimuli. The sensing may occur continuously or only upon command by the user (ie once they suspect that they are in the tissue or cavity).
-
FIGS. 9A-9D show side views of the sensor incorporated into the instrument. In this image, the instrument 91 (in this case a needle or trocar) contains asensor 92 at its tip which may intermittently or continuously provide information to the user to indicate plane of insertion. In this illustration, the instrument is shown passing through the subcutaneous tissues andmuscular layers 93 and entering thecavity 95 without harming or penetrating the tissues beneath. Examples where this illustration apply include: peritoneal cavity access, pleural cavity access, cerebrospinal cavity access, etc. In each of these cases, entrance into the space may be required but the underlying tissues (the intestines/liver, lungs and spinal cord/brain, respectively) are sensitive and a sensing technology to prevent over-insertion would be a significant advance in the state of the art. In addition to the sensors detection of 1) changes in the physical properties surrounding the instrument such as pressure, acceleration, forces or other physical properties, 2) chemical changes surrounding the instrument, ie the presence or absence of compounds such as albumin, hemoglobin, glucose or the pH or other chemical properties, or 3) changes in the electrical properties such as conductance, resistance, impedance, capacitance, etc. of the tissues 4) changes in the acoustic or vibratory properties of the tissues, and/or 5) changes in optical properties such as refraction of light within the tissue to detect instrument entrance into the cavity, 6) and/or changes in the thermal properties of the tissues the same sensor, or another sensor, may be capable of detecting other components that signal an issue may have occurred during entry. For example, with the peritoneal catheter example, the sensor, or another sensor, may be able to detect the presence of fecal matter or blood which would indicate that even though the cavity may have been entered, the catheter may been over-inserted or is not in its correct position. This positive feedback related to instrument entry and negative feedback with respect to possible incorrect positioning of the instrument, in combination, provide confidence to the user not only that the correct cavity, space or tissues have been accessed but that no complications have arisen during the access procedure. - One example of this embodiment is a peritoneal access catheter with an electrical inductance sensor at its tip. The subcutaneous space has a different inductance compared to the peritoneal space which also has a different inductance than the intestinal lumen. In accessing the peritoneal cavity, then, the catheter may be advanced until the subcutaneous tissue inductance readings change to the peritoneal cavity inductance levels. Once the peritoneal cavity is sensed, based on the change in electrical properties, the catheter then provides feedback that the cavity has been accessed. In the event that the catheter is over-inserted into the bowel, the inductance will be dramatically lower than that found in the subcutaneous tissue or peritoneal space and this complication can be rapidly reported. In addition, iron-rich blood has a higher inductance than any of the other tissues and exposure to concentrated blood can be quickly reported if the catheter experiences this fluid. The cutoff may be set, as well, so that dilute blood does not trigger the sensor since minor capillaries may be ruptured in the normal access procedure. This same technique may be used, in reverse, to purposefully access the vascular space. In fact, most tissues have characteristic electrical properties and virtually any tissue, cavity or space may be accessed through monitoring for this signal during instrument insertion. This is just one embodiment and the access device may be used to access any body tissue, space, or cavity and may do so with feedback from any of the sensors detailed above or any other sensing technology.
-
FIGS. 10A-10E are side views of the sensor incorporated into removable insertion trocar. In this instance, the sensor is not incorporated into the catheter itself, but is instead coupled with an insertion tool, in this case acentral insertion trocar 107. Once the tissue, space, or cavity has been accessed, the insertion trocar may be removed 8 and the catheter advanced or left in place to allow access to the tissue or space for the intervention. -
FIGS. 11A-11E illustrate side views of thesensor 118 incorporated intoremovable sheath 119. In this embodiment, thesheath sensor 118 reports entry into the space then the access instrument 1110 is left in thecavity 1111 while theinsertion sheath 119 is removed. This embodiment is particularly appealing in instance where, once access is confirmed, future confirmation is not required since the sensor is removed along with the sheath. This embodiment is most useful, then, in instances where the instrument 1110 will remain in place for a long period of time (i.e. an implantable device with long-term action) or where the desired profile of the instrument 1110 is sufficiently small that inclusion of thesensor 118 into the instrument 1110 itself becomes technically challenging and economically impractical. -
FIGS. 12A-12C demonstrate side views of the External Reader attached to the access device. In this embodiment, theexternal reader 1212 may have adisplay 1213 or some other form of alert to let the user know that the access device has entered the correct cavity, or in which cavity the sensor currently resides. In its optimal embodiment, the sensor will provide information related to the tissue surrounding the sensor continuously and in real-time so that informed decisions to advance or retract the access device may be made. This illustration depicts the sensor incorporated within a removable insertion trocar, but it is important to note that this external reader and any other method of reporting device position to the user may be used with any of the sensing technologies described in this text or illustrated in these drawings. -
FIGS. 13A-13D illustrate side-views of the continuous reader incorporated into access device. In this embodiment, theintegrated reader 1314 may have adisplay 1315 or some other form of alert to let the user know that the access device has entered the correct cavity, or in which cavity the sensor currently resides. As with the external reader ofFIG. 12 , in its optimal embodiment, the sensor will provide information related to the tissue surrounding the sensor continuously and in real-time so that informed decisions to advance or retract the access device may be made. This illustration depicts the sensor incorporated within a removable insertion trocar, but it⋅ is important to note that this external reader and any other method of reporting device position to the user may be used with any of the sensing technologies described in this text or illustrated in these drawings. As with any of the embodiments described, the sensing device (here shown as the insertion trocar), may be disposable or reusable. -
FIGS. 14A-14D illustrate side-views of the intermittent reader incorporated in.to the access device. In this embodiment, the integrated reader may have a display or some other form of alert to let the user know that the access device has entered the correct cavity, or in which cavity the sensor currently resides. As with the integrated reader ofFIG. 13 , in its optimal embodiment, the sensor will provide information related to the tissue surrounding the sensor, but will do so only when activated, in this instance via deployment of a reversible a push-button 1416 at the end of the insertion device. This intermittent reading may give exact tissue location information, as well, and may be deployed repeatedly. This embodiment is particularly appealing for sensing technologies, ie optical, that may produce heat or other potentially harmful byproducts and should, ideally, only be activated for brief periods of time. As with other embodiments, informed decisions to the advancement or retraction of the access device may be made. This illustration depicts the sensor incorporated within a removable insertion trocar, but it is important to note that this external reader and any other method of reporting device position to the user may be used with any of the sensing technologies described in this text or illustrated in these drawings. As with any of the embodiments described, the sensing device (here shown as the insertion trocar), may be disposable or reusable. -
FIGS. 15A-15E illustrate side-views of the sensor incorporated into a catheter, this time again with the central trocar embodiment. In this embodiment, as withFIG. 11 , a sensor may be incorporated into the external sheath surrounding an insertion trocar. In contrast, though, in this embodiment the insertion trocar may be removed and the sensor-containingsheath 1517 may remain within the cavity. This embodiment is particularly useful for catheter insertion and advancement (as illustrated in successful illustration from top to bottom). Using the sensor at the tip, catheter position may be continuously or intermittently assessed while it is advanced thereby ensuring that the catheter is not only in position when the trocar is removed, but that it remains within the correct cavity while it is advanced. The catheter or sheath may be single or multiple lumen catheter and may employ a sensor incorporated into instrument or an external sensor. The catheter may also use additional sensors or lumens or other communication means to external sensors in order to provide the desire intervention or therapy. One preferred embodiment of this device describes a method of accessing the peritoneal cavity with a catheter. In this embodiment, the sensor-containing catheter may be advanced using the central trocar as a stiffening element. This insertion procedure may employ a blunt dissecting instrument or may utilize the Seldinger technique (or modification thereof). Once the catheter or sheath begins to move through the tissues, though, the sensor at the tip may report position to the user, either intermittently or—ideally—continuously, indicating which tissues are surrounding the sensor. Once the peritoneal cavity has been accessed, in this embodiment, the reader, either external or integrated within the access device, reports that the cavity has been accessed via visual, auditory or tactile stimuli. The central trocar may then be removed and the catheter advanced, once again during continuous monitoring by the sensor in its optimal embodiment. If the catheter moves from the peritoneal cavity (ie into subcutaneous tissues, muscle, bowel or any other organ) or becomes surrounded by another fluid (blood, urine, etc.) then the sensor may report the change and indicate to the user that the device is no longer optimally placed and that further intervention (whether it be simply adjusting the catheter or performing further investigation) is required. Using this device and method, the user may ensure precise and consistent access to the peritoneal cavity not only upon insertion but for the duration of the placement of the device and through any required manipulations. -
FIG. 16 details the embodiment wherein intravenous fluid delivery may be automated, or manually adjusted, based on feedback from one or more sensors. In this embodiment, theinfusion catheter 1618 may preferably have a sensor to aid in insertion, but this is not necessary for this invention. In the ideal embodiment, the infusion catheter also is used to detect the parameters used to optimize therapy, namely electrocardiograph monitoring, electroencephalograph monitoring, pulse oximetry (either internally or peripherally), blood pressure, central venous pressure, cardiac output, cardiac stroke volume, cardiac rate, blood flow (i.e. in superior mesenteric, celiac, renal or other arteries), total circulating blood volume, pressure in veins (particularly those that empty, into the IVC, i.e. femoral vein), pressure in arteries (particularly those distal to the aorta, i.e. the femoral artery), blood oxygenation (i.e. in rectal mucosa, peripheral fingers arid toes, etc.), whole body oxygen consumption, pH, arterial p02, or any other parameter that shows a measurable change with intravascular volume overload. Additional catheters, here envisioned as a peripherally inserted central catheter (PICC) 1619, orbladder catheter 1620, or additional sensors on this infusion catheter may be used to monitor these, or other, parameters, though to optimize the infusion rate and achieve euvolemia without fluid overload or dehydration. This information may then be transmitted to acentral controller 1621, which integrates all of this information to determine the flow of intravenous fluid. This may be used to achieve or maintain euvolemia (ie in sepsis, hemorrhagic shock, etc.) or to maximize infusion for delivery of a therapeutic agent, i.e. chilled fluid and/or solids to achieve hypothermia. The sensor or sensors, whether cables/catheters or percutaneous monitoring technologies—wired or wireless, may also be disparate from the infusion line so long as the information from this sensor or sensors is transferred to the control unit in order to optimize fluid flow. In this embodiment, as well, the device of the current invention may or may not incorporate the access sensor, but may utilize sensors to optimize therapy. One example of such a device is a peripheral venous, central venous or arterial catheter that is capable of maintaining hydration without causing fluid overload. Said catheter may incorporate a sensor which may detect central venous pressure, total circulating blood volume, peripheral venous pressure, cardiac output or osmolarity, and/or solute concentrations (ie chloride, sodium, etc.) in order to prevent fluid overload. The sensor may also be external to said catheter, so long as the output of said sensor is capable of controlling fluid flow through the catheter. In this embodiment, said fluid flow is controlled by the output of said sensor which is integrated by a fluid flow control unit which alters the rate of fluid flow based on this output. This embodiment may allow the user to bolus large volumes of fluids or solids into the vascular space in order to rehydrate, induce hypothermia or induce hypothermia, or deliver a therapeutic agent or maintain blood pressure in sepsis. In addition, this technology may provide a fully automated mechanism to optimize fluid flow into the vessel without fluid overloading the patient. Without this automated fluid delivery coupled to hemodynamic parameter monitoring, the patient is in danger of dehydration or fluid overload from any vascular infusion. This technology may also be applied to liquid or solid infusion into any body cavity or space in so long as the fluid flow is automated based on feedback from sensors within the body (ideally incorporated into the catheter itself) in order to optimize the volume of infusion. This device and method of automating fluid flow based on hemodynamic sensor-based feedback may also be used to generate intravenous hypothermia. In its current state, IV hypothermia induction is limited due to concerns of fluid overload. If the hemodynamic parameters of the patient can be measured and fluid flow directly or indirectly controlled based on the output of these measurements, the volume of fluid can be maximized while ensuring hemodynamic instability. In this embodiment, the sensor may be, ideally, incorporated within the catheter and fluid flow into the vasculature may be tailored based on central venous pressure, total circulating blood volume, peripheral venous pressure, cardiac output or osmolarity, and/or solute .concentrations (ie chloride, sodium, etc.) in order to prevent fluid overload. In its optimal embodiment, the fluid infusion catheter also may function as a thermodilution cardiac output sensor such that the same fluid that is used to generate hypothermia may also be used to detect cardiac output. This information may then be relayed, either directly or indirectly, back to the fluid infusion controller to increase, decrease or even halt fluid flow based on these parameters, ie if cardiac output is low and venous pressure or total circulating volume is low, the patient has a low circulating volume and large volumes of fluid may be safely delivered. If the cardiac output is normal, fluid may also be safely delivered, but the cardiac output must be monitored to ensure that it does not begin to decrease (an indication of fluid overload). This same system may be used to infuse normal fluids or hypothermic fluids to sepsis patients or patients requiring intensive maintenance of their hemodynamic status. Sepsis patients that are aggressively monitored do much better than those that are not. This is very nurse-intensive, though, so a system that provides automated optimal fluid infusion based on sensed parameters to ensure that fluid overload does not occur and that fluid infusion is not insufficient. This device providing for the automated sensor-based input to control fluid flow and method of delivering fluid using this system may be applicable to a wide range of conditions and should not be limited to the narrow scope of the conditions requiring fluid infusion described here. - While this description has focused largely on the method and device for peritoneal insertion, this same procedure and method may be used to access any body cavity, tissue or space reliably and consistently with confidence. In using this technology, clinician's may be confident that their instrument resides in its desired space without the requirement for complex instrumentation or costly imaging techniques. For example, in its preferred embodiment this method and device may be used in conjunction with any access device that currently requires imaging to confirm placement, but without the need for ionizing radiation. Examples of such devices include nasogastric tubes, central venous lines, chest tubes, feeding tubes, etc.
- Communications between the sensor and display or instrument control unit may also be done wirelessly, ie via RFID or Bluetooth. In the instance where the catheter is a dual lumen catheter, one lumen may be used for fluid delivery while the other may be used for fluid return and a temperature and/or pressure sensor may be incorporated along its length, ideally closer to the fluid return tubing than the fluid delivery tubing.
- Furthermore, the logic controller of the present invention may provide improved safety by monitoring for any of the deleterious changes expected with excess fluid flow i.e. into the peritoneal cavity or vascular space. Examples of monitored parameters that may signal a warning or automatically result in an adjustment to rate of fluid infusion/extraction and/or fluid temperature include: electrocardiograph monitoring, electro-encephalograph monitoring, pulse oximetry (either internally or peripherally), peritoneal cavity compliance, intrathoracic pressure, intraperitoneal pressure, bladder pressure, rectal pressure, cardiac output, cardiac stroke volume, cardiac rate, blood flow (i.e. in superior mesenteric, celiac, renal or other arteries), pressure in veins (particularly those that empty into the IVC, i.e. femoral vein), pressure in arteries (particularly those distal to the aorta, i.e. the femoral artery), blood oxygenation (i.e. in rectal mucosa, peripheral fingers and toes, etc.), whole body oxygen consumption, pH and arterial p02 and any other parameter that shows a measurable change once the peritoneal or vascular spaces have been overloaded. These parameters, in particular, have been found to change with increases in peritoneal pressure with significantly negative impact on each parameter found at 40 mmHg, thus monitoring for these changes in conjunction with the peritoneal infusion catheter of the present invention will allow for even greater safety with peritoneal infusion. These parameters may be measured a variety of ways and the data transmitted either wirelessly or via wires to the logic controller in order to alert the healthcare provider or to automatically adjust the fluid flow/temperature in order to optimize both the flow of the peritoneal fluid and patient safety.
- While most of these embodiments have been written focusing on certain embodiments, i.e. a catheter technology, the invention may be used with any instrument that demands precise access to tissues, body cavities or spaces and/or requires automated, sensor-based intervention or therapy.
-
-
- I. Device: Peritoneal Access Safety System (PASS)
- II. Indications for Use (IFU): Any intervention requiring peritoneal access
- III. Preferred Methods for Use:
- a. Upon presentation with a condition fitting the criteria for IFU, the device of the present invention will be obtained and the patient will be prepared for paracentesis.
- b. The access system will then be advanced through the subcutaneous and deeper tissues slowly while the reader is closely observed to indicate the depth of the puncture.
- c. The reader indicates depth of puncture, ideally, based on the unique electrical signature (impedance, resistance, capacitance, etc.) of the tissue surrounding the sensr.
- d. Once the reader indicates that the cavity has been accessed, advancement ceases and the central insertion trocar may be removed and/or the catheter advanced.
- e. The soft, blunt-tipped catheter may be advanced slowly, once again while the position reader is observed.
- f. Once the catheter has been inserted to its desired depth the position is once again checked and, if the catheter has been correctly inserted, the intervention is performed.
- g. If the catheter position is not correct, corrective measures may be taken to ensure correct positioning prior to any intervention.
- h. Optionally, but preferably, the position sensor may continuously monitor position to ensure that the catheter does not migrate during the intervention.
- i. Optionally, but preferably, as well, the sensor may be used to indicate the occurrence of complications (ie presence of blood) with any intervention
- j. Optionally, but preferably, as well, the catheter may contain other sensor technology, ie pressure and/or temperature sensors, to guide therapeutic intervention such as optimization of peritoneal filling with peritoneal hypothermia or resuscitation
Claims (2)
1. An apparatus for accessing a body space within a body, comprising:
an elongate device configured for insertion into the body;
one or more sensors positioned on the elongate device such that the sensors define a plane which is perpendicular relative to an axis defined by the elongate device, wherein the one or more sensors are positioned to contact tissue adjacent to the elongate device during advancement into the body;
a controller in communication with the one or more sensors, wherein the controller is configured to receive one or more signals from the tissue in contact with the one or more sensors and detect a change in a property of the tissue as the elongate device is advanced, and
wherein the controller is further configured to determine a position of the elongate device relative to the body space based upon the change detected in the property as the elongate device is advanced.
2. A method for accessing a body space within a body, comprising:
advancing an elongate device into the body while contacting tissue adjacent to the elongate device during advancement via one or more sensors positioned on the elongate device, wherein the one or more sensors define a plane which is perpendicular relative to an axis defined by the elongate device;
receiving one or more signals from the tissue in contact with the one or more sensors;
detecting a change in a property of the tissue via a controller in communication with the one or more sensors as the elongate device is advanced; and
determining via the controller a position of the elongate device relative to the body space based upon the change detected in the property as the elongate device is advanced.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18/472,625 US20240008763A1 (en) | 2007-04-05 | 2023-09-22 | Device and method for safe access and automated therapy |
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92197407P | 2007-04-05 | 2007-04-05 | |
US12/098,365 US8100880B2 (en) | 2007-04-05 | 2008-04-04 | Automated therapy system and method |
US13/354,210 US8480648B2 (en) | 2007-04-05 | 2012-01-19 | Automated therapy system and method |
US13/937,102 US20130296984A1 (en) | 2007-04-05 | 2013-07-08 | Automated Therapy System and Method |
US15/013,813 US20170020724A1 (en) | 2007-04-05 | 2016-02-02 | Automated therapy system and method |
US15/993,483 US11800992B2 (en) | 2007-04-05 | 2018-05-30 | Device and method for safe access and automated therapy |
US18/472,625 US20240008763A1 (en) | 2007-04-05 | 2023-09-22 | Device and method for safe access and automated therapy |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/993,483 Continuation US11800992B2 (en) | 2007-04-05 | 2018-05-30 | Device and method for safe access and automated therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
US20240008763A1 true US20240008763A1 (en) | 2024-01-11 |
Family
ID=39595590
Family Applications (7)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/098,365 Expired - Fee Related US8100880B2 (en) | 2007-04-05 | 2008-04-04 | Automated therapy system and method |
US13/354,210 Active US8480648B2 (en) | 2007-04-05 | 2012-01-19 | Automated therapy system and method |
US13/937,102 Abandoned US20130296984A1 (en) | 2007-04-05 | 2013-07-08 | Automated Therapy System and Method |
US15/009,687 Abandoned US20160143774A1 (en) | 2007-04-05 | 2016-01-28 | Automated therapy system and method |
US15/013,813 Pending US20170020724A1 (en) | 2007-04-05 | 2016-02-02 | Automated therapy system and method |
US15/993,483 Active 2028-04-24 US11800992B2 (en) | 2007-04-05 | 2018-05-30 | Device and method for safe access and automated therapy |
US18/472,625 Pending US20240008763A1 (en) | 2007-04-05 | 2023-09-22 | Device and method for safe access and automated therapy |
Family Applications Before (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/098,365 Expired - Fee Related US8100880B2 (en) | 2007-04-05 | 2008-04-04 | Automated therapy system and method |
US13/354,210 Active US8480648B2 (en) | 2007-04-05 | 2012-01-19 | Automated therapy system and method |
US13/937,102 Abandoned US20130296984A1 (en) | 2007-04-05 | 2013-07-08 | Automated Therapy System and Method |
US15/009,687 Abandoned US20160143774A1 (en) | 2007-04-05 | 2016-01-28 | Automated therapy system and method |
US15/013,813 Pending US20170020724A1 (en) | 2007-04-05 | 2016-02-02 | Automated therapy system and method |
US15/993,483 Active 2028-04-24 US11800992B2 (en) | 2007-04-05 | 2018-05-30 | Device and method for safe access and automated therapy |
Country Status (6)
Country | Link |
---|---|
US (7) | US8100880B2 (en) |
EP (1) | EP2155300A1 (en) |
JP (1) | JP2010523230A (en) |
AU (1) | AU2008237177A1 (en) |
CA (1) | CA2684807A1 (en) |
WO (1) | WO2008124644A1 (en) |
Families Citing this family (120)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040087877A1 (en) | 2000-08-23 | 2004-05-06 | Besz William John | Catheter locator apparatus and method of use |
US9123077B2 (en) | 2003-10-07 | 2015-09-01 | Hospira, Inc. | Medication management system |
US8065161B2 (en) | 2003-11-13 | 2011-11-22 | Hospira, Inc. | System for maintaining drug information and communicating with medication delivery devices |
US7976518B2 (en) | 2005-01-13 | 2011-07-12 | Corpak Medsystems, Inc. | Tubing assembly and signal generator placement control device and method for use with catheter guidance systems |
US20070051409A1 (en) | 2005-09-02 | 2007-03-08 | Belmont Instrument Corporation | Pressure responsive fluid flow control valves |
US20070093697A1 (en) | 2005-10-21 | 2007-04-26 | Theranova, Llc | Method and apparatus for detection of right to left shunting in the cardiopulmonary vasculature |
US20180311071A1 (en) | 2005-10-21 | 2018-11-01 | Daniel R. BURNETT | Method and apparatus for peritoneal oxygenation |
AU2007317669A1 (en) | 2006-10-16 | 2008-05-15 | Hospira, Inc. | System and method for comparing and utilizing activity information and configuration information from mulitple device management systems |
JP2010523230A (en) | 2007-04-05 | 2010-07-15 | ベロメディックス,インク | Automatic treatment system and method |
US7819835B2 (en) | 2007-08-07 | 2010-10-26 | Belmont Instrument Corporation | Hyperthermia, system, method and components |
US11000407B2 (en) | 2007-08-07 | 2021-05-11 | Belmont Instrument, Llc | Hyperthermia, system, method, and components |
US9026370B2 (en) | 2007-12-18 | 2015-05-05 | Hospira, Inc. | User interface improvements for medical devices |
US10089443B2 (en) | 2012-05-15 | 2018-10-02 | Baxter International Inc. | Home medical device systems and methods for therapy prescription and tracking, servicing and inventory |
WO2012122267A1 (en) * | 2011-03-07 | 2012-09-13 | Theranova, Llc | Sensing foley catheter |
US8423112B2 (en) | 2008-09-30 | 2013-04-16 | Covidien Lp | Medical sensor and technique for using the same |
US8608696B1 (en) | 2009-02-24 | 2013-12-17 | North Carolina State University | Rapid fluid cooling devices and methods for cooling fluids |
US8271106B2 (en) | 2009-04-17 | 2012-09-18 | Hospira, Inc. | System and method for configuring a rule set for medical event management and responses |
US8346332B2 (en) * | 2009-06-10 | 2013-01-01 | Medtronic, Inc. | Absolute calibrated tissue oxygen saturation and total hemoglobin volume fraction |
US20100324827A1 (en) * | 2009-06-18 | 2010-12-23 | Nellcor Puritan Bennett Ireland | Fluid Responsiveness Measure |
US9622670B2 (en) | 2010-07-09 | 2017-04-18 | Potrero Medical, Inc. | Method and apparatus for pressure measurement |
US9962516B2 (en) | 2010-09-09 | 2018-05-08 | University Of Florida Research Foundation, Incorporated | Context-sensitive flow interrupter and drainage outflow optimization system |
WO2012103356A2 (en) * | 2011-01-26 | 2012-08-02 | Velomedix, Inc. | Dual thermistor redundant temperature sensor |
EP2514453B1 (en) * | 2011-04-19 | 2013-11-27 | Matthias Roth | Apparatus for controlling a body temperature |
US8926542B2 (en) | 2011-04-29 | 2015-01-06 | Medtronic, Inc. | Monitoring fluid volume for patients with renal disease |
US9240002B2 (en) | 2011-08-19 | 2016-01-19 | Hospira, Inc. | Systems and methods for a graphical interface including a graphical representation of medical data |
JP6033874B2 (en) | 2011-10-21 | 2016-11-30 | ホスピーラ インコーポレイテッド | Medical device update system |
US10022498B2 (en) | 2011-12-16 | 2018-07-17 | Icu Medical, Inc. | System for monitoring and delivering medication to a patient and method of using the same to minimize the risks associated with automated therapy |
AU2013239778B2 (en) | 2012-03-30 | 2017-09-28 | Icu Medical, Inc. | Air detection system and method for detecting air in a pump of an infusion system |
CA3089257C (en) | 2012-07-31 | 2023-07-25 | Icu Medical, Inc. | Patient care system for critical medications |
US20140073973A1 (en) * | 2012-09-10 | 2014-03-13 | Vanderbilt University | Intravenous access device having integrated hemodynamic resuscitation system and related methods |
EP2943243B1 (en) | 2013-01-14 | 2022-11-30 | Corpak Medsystems, Inc. | Bridle delivery system, method, and apparatus for securing nasal tubes |
WO2014138446A1 (en) | 2013-03-06 | 2014-09-12 | Hospira,Inc. | Medical device communication method |
AU2014268355B2 (en) | 2013-05-24 | 2018-06-14 | Icu Medical, Inc. | Multi-sensor infusion system for detecting air or an occlusion in the infusion system |
CA2913915C (en) | 2013-05-29 | 2022-03-29 | Hospira, Inc. | Infusion system which utilizes one or more sensors and additional information to make an air determination regarding the infusion system |
CA2913918C (en) | 2013-05-29 | 2022-02-15 | Hospira, Inc. | Infusion system and method of use which prevents over-saturation of an analog-to-digital converter |
US20150066531A1 (en) | 2013-08-30 | 2015-03-05 | James D. Jacobson | System and method of monitoring and managing a remote infusion regimen |
US9180260B2 (en) | 2013-08-30 | 2015-11-10 | Covidien Lp | Systems and methods for monitoring an injection procedure |
US9662436B2 (en) | 2013-09-20 | 2017-05-30 | Icu Medical, Inc. | Fail-safe drug infusion therapy system |
SE537628C2 (en) | 2013-11-08 | 2015-08-18 | Bonvisi Ab | Device for irrigation and insufflation with blood pressure dependent pressure control |
US10311972B2 (en) | 2013-11-11 | 2019-06-04 | Icu Medical, Inc. | Medical device system performance index |
AU2014353130B9 (en) | 2013-11-19 | 2019-09-05 | Icu Medical, Inc. | Infusion pump automation system and method |
ES2776363T3 (en) | 2014-02-28 | 2020-07-30 | Icu Medical Inc | Infusion set and method using dual wavelength in-line optical air detection |
WO2015168427A1 (en) | 2014-04-30 | 2015-11-05 | Hospira, Inc. | Patient care system with conditional alarm forwarding |
AU2015266706B2 (en) | 2014-05-29 | 2020-01-30 | Icu Medical, Inc. | Infusion system and pump with configurable closed loop delivery rate catch-up |
US9724470B2 (en) | 2014-06-16 | 2017-08-08 | Icu Medical, Inc. | System for monitoring and delivering medication to a patient and method of using the same to minimize the risks associated with automated therapy |
AU2015311787B2 (en) | 2014-09-04 | 2019-08-01 | Avent, Inc. | Gastric systems, apparatus, and methods for use with enteral feeding |
CN106999061B (en) * | 2014-09-12 | 2020-08-07 | 范德堡大学 | Hypovolemia/hypervolemia detection using peripheral intravenous waveform analysis (PIVA) and applications thereof |
US10531799B2 (en) * | 2014-09-12 | 2020-01-14 | Vanderbilt University | Intravenous access device detecting intravenous infiltration and in-vein placement |
US9539383B2 (en) | 2014-09-15 | 2017-01-10 | Hospira, Inc. | System and method that matches delayed infusion auto-programs with manually entered infusion programs and analyzes differences therein |
US11344668B2 (en) | 2014-12-19 | 2022-05-31 | Icu Medical, Inc. | Infusion system with concurrent TPN/insulin infusion |
CN107405083B (en) | 2015-02-12 | 2020-11-03 | 方德里创新研究第一有限公司 | Implantable devices for heart failure monitoring and related methods |
WO2018031714A1 (en) | 2016-08-11 | 2018-02-15 | Foundry Innovation & Research 1, Ltd. | Systems and methods for patient fluid management |
US10850024B2 (en) | 2015-03-02 | 2020-12-01 | Icu Medical, Inc. | Infusion system, device, and method having advanced infusion features |
US11224732B2 (en) | 2015-05-05 | 2022-01-18 | Avent, Inc. | Threaded connector port cleaning system, method, and apparatus |
WO2016189417A1 (en) | 2015-05-26 | 2016-12-01 | Hospira, Inc. | Infusion pump system and method with multiple drug library editor source capability |
CN105126237B (en) * | 2015-06-26 | 2018-04-24 | 中国人民解放军总医院 | A kind of double mode heart situ perfusion system |
CN105126238B (en) * | 2015-06-26 | 2018-11-27 | 中国人民解放军总医院 | A kind of heart situ perfusion system based on pressure signal gate |
MA45266A (en) * | 2015-07-20 | 2019-04-17 | Strataca Systems Ltd | CATHETER DEVICE AND METHOD FOR INDUCING NEGATIVE PRESSURE IN THE BLADDER OF A PATIENT |
US11040172B2 (en) | 2015-07-20 | 2021-06-22 | Strataca Systems Limited | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
US10918827B2 (en) | 2015-07-20 | 2021-02-16 | Strataca Systems Limited | Catheter device and method for inducing negative pressure in a patient's bladder |
US10926062B2 (en) | 2015-07-20 | 2021-02-23 | Strataca Systems Limited | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
EP3331426A1 (en) | 2015-08-03 | 2018-06-13 | Foundry Innovation&Research 1, Ltd. | Devices and methods for measurement of vena cava dimensions, pressure, and oxygen saturation |
US20180318128A1 (en) | 2015-09-30 | 2018-11-08 | SEIRATHERM GmbH | Temperature adjustment infusion system and method |
US20180318524A1 (en) | 2015-09-30 | 2018-11-08 | SEIRATHERM GmbH | Cooling infusion system and method |
CN108136109A (en) | 2015-09-30 | 2018-06-08 | 塞拉瑟姆有限责任公司 | Modular temperature regulating system and method |
EP3150242A1 (en) | 2015-09-30 | 2017-04-05 | seiratherm GmbH | Temperature adjustment infusion system and method |
WO2017055450A1 (en) * | 2015-09-30 | 2017-04-06 | SEIRATHERM GmbH | Intracranial pressure adjustment infusion system and method |
US20180271698A1 (en) | 2015-09-30 | 2018-09-27 | SEIRATHERM GmbH | Dual infusion system for temperature adjustment and method |
US10874790B2 (en) | 2016-08-10 | 2020-12-29 | Medtronic, Inc. | Peritoneal dialysis intracycle osmotic agent adjustment |
US10994064B2 (en) | 2016-08-10 | 2021-05-04 | Medtronic, Inc. | Peritoneal dialysate flow path sensing |
AU2017264784B2 (en) | 2016-05-13 | 2022-04-21 | Icu Medical, Inc. | Infusion pump system and method with common line auto flush |
EP3468635A4 (en) | 2016-06-10 | 2019-11-20 | ICU Medical, Inc. | Acoustic flow sensor for continuous medication flow measurements and feedback control of infusion |
WO2018005169A1 (en) * | 2016-06-29 | 2018-01-04 | Theranova, Llc | Devices and methods for vascular navigation, assessment and/or diagnosis |
EP3484541A4 (en) | 2016-07-14 | 2020-03-25 | ICU Medical, Inc. | Multi-communication path selection and security system for a medical device |
WO2018015300A1 (en) | 2016-07-22 | 2018-01-25 | SEIRATHERM GmbH | Medical tempering device and method for tempering infusion fluids |
US10758659B2 (en) | 2016-08-10 | 2020-09-01 | Medtronic, Inc. | Peritoneal dialysis filtrate sampling and adaptive prescription |
US10744253B2 (en) | 2016-08-10 | 2020-08-18 | Medtronic, Inc. | Adaptive peritoneal dialysis intra-session adjustments for overall session optimization |
US10537673B2 (en) | 2016-08-10 | 2020-01-21 | Medtronic, Inc. | Intersession adaptive peritoneal dialysis fluid removal for multiple session optimization |
WO2018031711A2 (en) * | 2016-08-10 | 2018-02-15 | Medtronic, Inc. | Catheter and peritoneum health monitoring |
US11701018B2 (en) | 2016-08-11 | 2023-07-18 | Foundry Innovation & Research 1, Ltd. | Wireless resonant circuit and variable inductance vascular monitoring implants and anchoring structures therefore |
US11206992B2 (en) | 2016-08-11 | 2021-12-28 | Foundry Innovation & Research 1, Ltd. | Wireless resonant circuit and variable inductance vascular monitoring implants and anchoring structures therefore |
US11013843B2 (en) | 2016-09-09 | 2021-05-25 | Medtronic, Inc. | Peritoneal dialysis fluid testing system |
DE202017007291U1 (en) | 2016-11-29 | 2020-11-30 | Foundry Innovation & Research 1, Ltd. | Wireless resonance switching and variable inductance vascular grafts for monitoring and systems using a patient's vasculature and fluid status |
US10137257B2 (en) | 2016-11-30 | 2018-11-27 | Belmont Instrument, Llc | Slack-time heating system for blood and fluid warming |
US10507292B2 (en) | 2016-11-30 | 2019-12-17 | Belmont Instrument, Llc | Rapid infuser with vacuum release valve |
US10485936B2 (en) | 2016-11-30 | 2019-11-26 | Belmont Instrument, Llc | Rapid infuser with advantageous flow path for blood and fluid warming |
US11638657B2 (en) | 2016-12-16 | 2023-05-02 | Avent, Inc. | Medical plug system, method, and apparatus |
US10219981B2 (en) | 2017-03-31 | 2019-03-05 | Integra Lifesciences Switzerland Sàrl | Fluid containers and systems and methods for detecting a fluid level therein |
US11540783B2 (en) * | 2017-04-28 | 2023-01-03 | University Of Washington | Alarm system for intravenous pump or catheter based upon fuzzy logic |
WO2018220143A1 (en) | 2017-05-31 | 2018-12-06 | Foundry Innovation And Research 1, Ltd | Implantable ultrasonic vascular sensor |
EP3629921A1 (en) | 2017-05-31 | 2020-04-08 | Foundry Innovation & Research 1, Ltd. | Implantable sensors for vascular monitoring |
DE102018122846A1 (en) | 2017-09-29 | 2019-04-04 | SEIRATHERM GmbH | Infusion system and method for temperature control |
US10089055B1 (en) | 2017-12-27 | 2018-10-02 | Icu Medical, Inc. | Synchronized display of screen content on networked devices |
CN112399865B (en) * | 2018-03-09 | 2022-09-27 | 1929803安大略Dba 弗洛索尼克斯医疗公司 | Dynamically controllable patient fluid control device |
US11139058B2 (en) | 2018-07-17 | 2021-10-05 | Icu Medical, Inc. | Reducing file transfer between cloud environment and infusion pumps |
US10964428B2 (en) | 2018-07-17 | 2021-03-30 | Icu Medical, Inc. | Merging messages into cache and generating user interface using the cache |
NZ793485A (en) | 2018-07-17 | 2023-06-30 | Icu Medical Inc | Systems and methods for facilitating clinical messaging in a network environment |
WO2020018567A1 (en) * | 2018-07-17 | 2020-01-23 | Theranova, Llc | Automated peritoneal organ support |
CA3106516C (en) | 2018-07-17 | 2023-07-25 | Icu Medical, Inc. | Updating infusion pump drug libraries and operational software in a networked environment |
US10692595B2 (en) | 2018-07-26 | 2020-06-23 | Icu Medical, Inc. | Drug library dynamic version management |
WO2020023231A1 (en) | 2018-07-26 | 2020-01-30 | Icu Medical, Inc. | Drug library management system |
EP3886817A1 (en) | 2018-11-27 | 2021-10-06 | Zaklady Farmaceutyczne Polpharma S.A. | Pharmaceutical composition comprising ramipril and indapamide |
US11806456B2 (en) | 2018-12-10 | 2023-11-07 | Mozarc Medical Us Llc | Precision peritoneal dialysis therapy based on dialysis adequacy measurements |
US11839723B2 (en) | 2019-03-04 | 2023-12-12 | Avent, Inc. | System, method, and apparatus for detecting tube misplacement in a patient's airway |
US11786141B2 (en) | 2019-03-04 | 2023-10-17 | Avent, Inc. | System, method, and apparatus for detecting tube misplacement in a patient's airway |
US11590320B2 (en) | 2019-04-04 | 2023-02-28 | Avent, Inc. | Two-in-one catheter and signal generating apparatus |
US11273288B2 (en) | 2019-04-08 | 2022-03-15 | Avent, Inc. | System and method for medical device position guidance |
US11602280B2 (en) | 2019-04-08 | 2023-03-14 | Avent, Inc. | In-scale flexible display for medical device position guidance |
US11517217B2 (en) | 2019-04-08 | 2022-12-06 | Avent, Inc. | In-scale tablet display for medical device position guidance |
CN114206412A (en) * | 2019-07-03 | 2022-03-18 | 费森尤斯医疗护理德国有限责任公司 | Catheter extension device for peritoneal dialysis and method for operating a catheter extension device |
US11278671B2 (en) | 2019-12-04 | 2022-03-22 | Icu Medical, Inc. | Infusion pump with safety sequence keypad |
US11937976B2 (en) | 2020-07-06 | 2024-03-26 | 1929803 Ontario Corp | Ultrasound patch with integrated flexible transducer assembly |
EP4178505A1 (en) | 2020-07-10 | 2023-05-17 | C° Change Surgical LLC | Injectable slush feed supply |
AU2021311443A1 (en) | 2020-07-21 | 2023-03-09 | Icu Medical, Inc. | Fluid transfer devices and methods of use |
US11135360B1 (en) | 2020-12-07 | 2021-10-05 | Icu Medical, Inc. | Concurrent infusion with common line auto flush |
CN113367928A (en) * | 2021-04-30 | 2021-09-10 | 林明高 | Diagnosis and treatment bed for cardiovascular and cerebrovascular department |
WO2022266584A1 (en) * | 2021-06-16 | 2022-12-22 | Potrero Medical, Inc. | Systems, devices and methods for draining and analyzing bodily fluids, pressures and assessing health |
US11850344B2 (en) | 2021-08-11 | 2023-12-26 | Mozarc Medical Us Llc | Gas bubble sensor |
WO2023049440A1 (en) * | 2021-09-27 | 2023-03-30 | Becton, Dickinson And Company | System, method, and computer program product for vascular access management |
US11965763B2 (en) | 2021-11-12 | 2024-04-23 | Mozarc Medical Us Llc | Determining fluid flow across rotary pump |
Family Cites Families (331)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2078786A (en) * | 1934-12-17 | 1937-04-27 | Wood Glen Mason | Applicator and control means therefor |
US3042042A (en) * | 1958-03-14 | 1962-07-03 | Blanck Joachim Hillard | Stomach pump |
US3505988A (en) * | 1967-04-11 | 1970-04-14 | Norman Deane | Prosthesis for chronic access to the peritoneum |
US3630198A (en) * | 1969-06-23 | 1971-12-28 | Henkin Melvyn Lane | Catheter placement device |
US3698396A (en) * | 1970-12-04 | 1972-10-17 | Abbott Lab | Catheter assembly for peritoneal cavity insertion |
US3769497A (en) * | 1971-09-10 | 1973-10-30 | Hoffmann La Roche | Urine liquid discharge monitor |
US3927980A (en) | 1973-08-22 | 1975-12-23 | Baxter Laboratories Inc | Oxygen overpressure protection system for membrane-type blood oxygenators |
SE436660B (en) | 1979-01-25 | 1985-01-14 | Gambro Crafon Ab | DEVICE FOR SEATING TEMPERATURE AND SETTING ASTADCOM A DEVICE FOR SEATING TEMPERATURE |
US4356826A (en) * | 1979-05-09 | 1982-11-02 | Olympus Optical Co., Ltd. | Stabbing apparatus for diagnosis of living body |
US4445500A (en) * | 1982-03-03 | 1984-05-01 | Thomas Jefferson University | Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders |
US4657532A (en) * | 1985-07-19 | 1987-04-14 | Thomas Jefferson University | Intra-peritoneal perfusion of oxygenated fluorocarbon |
US4343316A (en) * | 1980-05-16 | 1982-08-10 | C. R. Bard, Inc. | Electronic urine flow monitor |
US4424806A (en) | 1981-03-12 | 1984-01-10 | Physio-Control Corporation | Automated ventilation, CPR, and circulatory assistance apparatus |
US4413633A (en) | 1981-06-01 | 1983-11-08 | Yanda Roman L | Method and apparatus for monitoring body conditions |
US4417585A (en) * | 1981-07-30 | 1983-11-29 | Frank Ulrich A | Liquid monitor |
US4450841A (en) * | 1982-03-03 | 1984-05-29 | Thomas Jefferson University | Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders |
US4535773A (en) * | 1982-03-26 | 1985-08-20 | Inbae Yoon | Safety puncturing instrument and method |
US4883459A (en) * | 1983-07-29 | 1989-11-28 | Reynaldo Calderon | Retrograde perfusion |
US4497324A (en) | 1983-10-03 | 1985-02-05 | American Hospital Supply Corporation | Temperature monitoring catheter |
JPS6247335A (en) * | 1985-08-23 | 1987-03-02 | カミノ ラボラトリ−ズ インク | Catheter apparatus |
JPH06104120B2 (en) * | 1986-05-02 | 1994-12-21 | アラン エム ピ−バデイ | Peritoneal dialysis device with continuous flow |
IL78756A0 (en) | 1986-05-12 | 1986-08-31 | Biodan Medical Systems Ltd | Catheter and probe |
US4836214A (en) | 1986-12-01 | 1989-06-06 | Bomed Medical Manufacturing, Ltd. | Esophageal electrode array for electrical bioimpedance measurement |
US4762130A (en) | 1987-01-15 | 1988-08-09 | Thomas J. Fogarty | Catheter with corkscrew-like balloon |
JPH0340303Y2 (en) * | 1987-04-16 | 1991-08-23 | ||
US4808157A (en) | 1987-07-13 | 1989-02-28 | Neuro Delivery Technology, Inc. | Multi-lumen epidural-spinal needle |
US4919134A (en) | 1987-07-31 | 1990-04-24 | Becton, Dickinson And Company | Thermoelectric chiller and automatic syringe |
US4921481A (en) | 1988-03-23 | 1990-05-01 | Abbott Laboratories | Enteral feeding system utilizing gastrointestinal myoelectrography |
US4904237A (en) * | 1988-05-16 | 1990-02-27 | Janese Woodrow W | Apparatus for the exchange of cerebrospinal fluid and a method of treating brain and spinal cord injuries |
US5249585A (en) | 1988-07-28 | 1993-10-05 | Bsd Medical Corporation | Urethral inserted applicator for prostate hyperthermia |
US5456251A (en) | 1988-08-26 | 1995-10-10 | Mountpelier Investments, S.A. | Remote sensing tonometric catheter apparatus and method |
US5108364A (en) | 1989-02-16 | 1992-04-28 | Sumitomo Bakelte Company Limited | Monitoring catheter for medical use |
US5263485A (en) | 1989-09-18 | 1993-11-23 | The Research Foundation Of State University Of New York | Combination esophageal catheter for the measurement of atrial pressure |
US5141493A (en) * | 1990-01-26 | 1992-08-25 | Sarcos Group | Peritoneal dialysis system |
US5395342A (en) | 1990-07-26 | 1995-03-07 | Yoon; Inbae | Endoscopic portal |
US5584804A (en) * | 1990-10-10 | 1996-12-17 | Life Resuscitation Technologies, Inc. | Brain resuscitation and organ preservation device and method for performing the same |
US5149321A (en) * | 1990-10-10 | 1992-09-22 | Klatz Ronald M | Brain resuscitation device and method for performing the same |
US5261891A (en) | 1991-01-15 | 1993-11-16 | Ethicon, Inc. | Trocar |
US5122267A (en) * | 1991-01-24 | 1992-06-16 | Oceanic Systems, Inc. | Foam fractionation filter |
US5693017A (en) | 1991-02-14 | 1997-12-02 | Wayne State University | Apparatus and method of delivery of gas-supersaturated solutions to a delivery site |
GB2254253A (en) | 1991-04-05 | 1992-10-07 | Deborah Jill Colson | A combined naso-gastric feeding tube and electrode |
US5188618A (en) | 1991-05-03 | 1993-02-23 | Thomas Bruce W | Thrombus-mobilizing thoracostomy tube |
CA2042449C (en) * | 1991-05-13 | 1997-02-04 | Joseph E. Dadson | Peritoneal dialysis apparatus |
US5199442A (en) * | 1991-05-20 | 1993-04-06 | Seager Stephen W J | Apparatus for reduction of spasticity in male and female patients having spinal cord injury as well as obtaining semen from males by stimulation of ejaculatory nerves |
US5245367A (en) * | 1991-11-12 | 1993-09-14 | David Miller | Annular mask contact lenses |
WO1993013718A1 (en) | 1992-01-21 | 1993-07-22 | Valleylab, Inc. | Electrosurgical control for a trocar |
US5709661A (en) * | 1992-04-14 | 1998-01-20 | Endo Sonics Europe B.V. | Electronic catheter displacement sensor |
US5476434A (en) * | 1992-05-27 | 1995-12-19 | Kalb; Irvin M. | Female incontinence device including electronic sensors |
AU659261B2 (en) | 1992-06-19 | 1995-05-11 | Conmed Corporation | Electrosurgical trocar assembly |
FR2693179B1 (en) * | 1992-07-03 | 1994-10-14 | Martin Sa | Sheet retainer for a stacking magazine. |
US5282962A (en) * | 1992-07-17 | 1994-02-01 | Chen Chi Der | Protein skimmer and power head thereof |
US5354277A (en) | 1992-09-04 | 1994-10-11 | Biocontrol Technology, Inc. | Specialized perfusion protocol for whole-body hyperthermia |
US5837003A (en) * | 1993-02-10 | 1998-11-17 | Radiant Medical, Inc. | Method and apparatus for controlling a patient's body temperature by in situ blood temperature modification |
US6620188B1 (en) | 1998-08-24 | 2003-09-16 | Radiant Medical, Inc. | Methods and apparatus for regional and whole body temperature modification |
US6110168A (en) | 1993-02-10 | 2000-08-29 | Radiant Medical, Inc. | Method and apparatus for controlling a patient's body temperature by in situ blood temperature modifications |
US6346074B1 (en) * | 1993-02-22 | 2002-02-12 | Heartport, Inc. | Devices for less invasive intracardiac interventions |
DE69427764T2 (en) | 1993-04-09 | 2001-10-31 | Applied Med Resources | SURGICAL TROCAR WITH SWITCH-OFF DEVICE |
US5991650A (en) | 1993-10-15 | 1999-11-23 | Ep Technologies, Inc. | Surface coatings for catheters, direct contacting diagnostic and therapeutic devices |
JP3387602B2 (en) | 1993-12-27 | 2003-03-17 | テルモ株式会社 | Intraperitoneal indwelling catheter |
JPH07275358A (en) * | 1994-04-05 | 1995-10-24 | Meteku:Kk | Peritoneum dialysis fluid exchanging device |
US5478329A (en) | 1994-05-06 | 1995-12-26 | Ternamian; Artin M. | Trocarless rotational entry cannula |
US5623940A (en) | 1994-08-02 | 1997-04-29 | S.L.T. Japan Co., Ltd. | Catheter apparatus with a sensor |
US5810742A (en) | 1994-10-24 | 1998-09-22 | Transcan Research & Development Co., Ltd. | Tissue characterization based on impedance images and on impedance measurements |
US5554280A (en) * | 1995-05-15 | 1996-09-10 | Loehr; Gary | Filter system |
US5995860A (en) * | 1995-07-06 | 1999-11-30 | Thomas Jefferson University | Implantable sensor and system for measurement and control of blood constituent levels |
US5865801A (en) | 1995-07-18 | 1999-02-02 | Houser; Russell A. | Multiple compartmented balloon catheter with external pressure sensing |
US5562821A (en) * | 1995-07-21 | 1996-10-08 | Commonwealth Of Puerto Rico | Foam fractionator |
US5730720A (en) * | 1995-08-18 | 1998-03-24 | Ip Scientific, Inc. | Perfusion hyperthermia treatment system and method |
US5755756A (en) * | 1995-09-15 | 1998-05-26 | Freedman, Jr.; Robert J. | Hypothermia-inducing resuscitation unit |
JPH09108340A (en) * | 1995-10-09 | 1997-04-28 | Baxter Internatl Inc | Automatic feeding and discharging apparatus for peritoneal dialysis |
US5665227A (en) * | 1995-11-29 | 1997-09-09 | Watt; Ronald | Dual-flow protein skimmer |
JP3737553B2 (en) | 1996-01-09 | 2006-01-18 | 株式会社東海理化電機製作所 | Catheter with sensor function |
US6066163A (en) * | 1996-02-02 | 2000-05-23 | John; Michael Sasha | Adaptive brain stimulation method and system |
JP3526690B2 (en) * | 1996-04-26 | 2004-05-17 | 富雄 太田 | Extracorporeal circulation device for separate cooling method |
US5758643A (en) * | 1996-07-29 | 1998-06-02 | Via Medical Corporation | Method and apparatus for monitoring blood chemistry |
KR100378358B1 (en) | 1996-07-30 | 2003-05-27 | 삼성전자주식회사 | Apparatus for measuring body temperature |
US5951497A (en) | 1996-09-03 | 1999-09-14 | Clinical Innovation Associates, Inc. | Pressure catheter device with enhanced positioning features |
US5891035A (en) * | 1996-09-25 | 1999-04-06 | Atl Ultrasound, Inc. | Ultrasonic diagnostic imaging system with data access and communications capability |
WO1998017333A2 (en) * | 1996-10-22 | 1998-04-30 | Hemocleanse, Inc. | Continuous flow-through peritoneal dialysis (cfpd) method with control of intraperitoneal pressure |
US6019729A (en) * | 1996-11-15 | 2000-02-01 | Kabushiki Kaisha Tokai-Rika-Denki-Seisakusho | Sensor mechanism-equipped catheter |
ATE307536T1 (en) * | 1997-04-01 | 2005-11-15 | Axel Muntermann | DEVICE FOR DETECTING CATHETER TISSUE CONTACT AND INTERACTIONS WITH TISSUE DURING CATHETER ABLATION |
US7264680B2 (en) * | 1997-05-09 | 2007-09-04 | Semitool, Inc. | Process and apparatus for treating a workpiece using ozone |
EP0904797A3 (en) * | 1997-09-24 | 2000-08-09 | ECLIPSE SURGICAL TECHNOLOGIES, Inc. | Steerable catheter with tip alignment and surface contact detector |
US5916153A (en) | 1997-10-27 | 1999-06-29 | Rhea, Jr.; W. Gardner | Multifunction catheter |
US6471717B1 (en) * | 1998-03-24 | 2002-10-29 | Innercool Therapies, Inc. | Selective organ cooling apparatus and method |
US6558412B2 (en) * | 1998-01-23 | 2003-05-06 | Innercool Therapies, Inc. | Selective organ hypothermia method and apparatus |
US6312452B1 (en) * | 1998-01-23 | 2001-11-06 | Innercool Therapies, Inc. | Selective organ cooling catheter with guidewire apparatus and temperature-monitoring device |
US6991645B2 (en) | 1998-01-23 | 2006-01-31 | Innercool Therapies, Inc. | Patient temperature regulation method and apparatus |
US6974463B2 (en) | 1999-02-09 | 2005-12-13 | Innercool Therapies, Inc. | System and method for patient temperature control employing temperature projection algorithm |
US6261312B1 (en) * | 1998-06-23 | 2001-07-17 | Innercool Therapies, Inc. | Inflatable catheter for selective organ heating and cooling and method of using the same |
US6464716B1 (en) * | 1998-01-23 | 2002-10-15 | Innercool Therapies, Inc. | Selective organ cooling apparatus and method |
US7458984B2 (en) | 1998-01-23 | 2008-12-02 | Innercool Therapies, Inc. | System and method for inducing hypothermia with active patient temperature control employing catheter-mounted temperature sensor and temperature projection algorithm |
US7371254B2 (en) * | 1998-01-23 | 2008-05-13 | Innercool Therapies, Inc. | Medical procedure |
JP4025506B2 (en) | 1998-01-23 | 2007-12-19 | ヴィアサーク・インコーポレーテッド | Whole body thermotherapy device and whole body thermotherapy |
US6149624A (en) | 1998-02-05 | 2000-11-21 | Mcshane; Richard Houston | Apparatus and method for the rapid induction of hypothermic brain preservation |
US6599312B2 (en) * | 1998-03-24 | 2003-07-29 | Innercool Therapies, Inc. | Isolated selective organ cooling apparatus |
US6159160A (en) * | 1998-03-26 | 2000-12-12 | Ethicon, Inc. | System and method for controlled infusion and pressure monitoring |
US6645234B2 (en) | 1998-04-21 | 2003-11-11 | Alsius Corporation | Cardiovascular guiding catheter with heat exchange properties and methods of use |
US6419643B1 (en) | 1998-04-21 | 2002-07-16 | Alsius Corporation | Central venous catheter with heat exchange properties |
US6338727B1 (en) | 1998-08-13 | 2002-01-15 | Alsius Corporation | Indwelling heat exchange catheter and method of using same |
US7287398B2 (en) * | 2001-09-25 | 2007-10-30 | Alsius Corporation | Heating/cooling system for indwelling heat exchange catheter |
US6368304B1 (en) | 1999-02-19 | 2002-04-09 | Alsius Corporation | Central venous catheter with heat exchange membrane |
US6520933B1 (en) | 1998-04-21 | 2003-02-18 | Alsius Corporation | Central venous line cooling catheter having a spiral-shaped heat exchange member |
US6126684A (en) | 1998-04-21 | 2000-10-03 | The Regents Of The University Of California | Indwelling heat exchange catheter and method of using same |
US6682551B1 (en) | 1999-03-11 | 2004-01-27 | Alsius Corporation | Method and system for treating cardiac arrest using hypothermia |
US6716236B1 (en) | 1998-04-21 | 2004-04-06 | Alsius Corporation | Intravascular catheter with heat exchange element having inner inflation element and methods of use |
US6581403B2 (en) | 2001-09-25 | 2003-06-24 | Alsius Corporation | Heating/cooling system for indwelling heat exchange catheter |
US6530946B1 (en) | 1998-04-21 | 2003-03-11 | Alsius Corporation | Indwelling heat exchange heat pipe catheter and method of using same |
US6149670A (en) | 1999-03-11 | 2000-11-21 | Alsius Corporation | Method and system for treating cardiac arrest using hypothermia |
US7255709B2 (en) | 1998-04-21 | 2007-08-14 | Alsius Corporation | Intravascular heat exchange catheter with temperature sensor |
US6458150B1 (en) | 1999-02-19 | 2002-10-01 | Alsius Corporation | Method and apparatus for patient temperature control |
US6337994B1 (en) | 1998-04-30 | 2002-01-08 | Johns Hopkins University | Surgical needle probe for electrical impedance measurements |
US6056766A (en) | 1998-06-09 | 2000-05-02 | Thompson; Ronald J. | Stabilized trocar, and method of using same |
IL124963A0 (en) | 1998-06-17 | 1999-01-26 | Abramovitch Aharon | Tracheal intubation stylet and improved methods of intubation and of lung function physiologic research and of functional pulmunologic diagnosis |
US6175688B1 (en) | 1998-07-10 | 2001-01-16 | Belmont Instrument Corporation | Wearable intravenous fluid heater |
US6450990B1 (en) | 1998-08-13 | 2002-09-17 | Alsius Corporation | Catheter with multiple heating/cooling fibers employing fiber spreading features |
US6673098B1 (en) * | 1998-08-24 | 2004-01-06 | Radiant Medical, Inc. | Disposable cassette for intravascular heat exchange catheter |
US6620189B1 (en) * | 2000-02-28 | 2003-09-16 | Radiant Medical, Inc. | Method and system for control of a patient's body temperature by way of a transluminally insertable heat exchange catheter |
US6610083B2 (en) | 1998-08-24 | 2003-08-26 | Radiant Medical, Inc. | Multiple lumen heat exchange catheters |
CA2340749A1 (en) | 1998-09-11 | 2000-03-23 | Medivance Inc. | Method and apparatus for providing localized heating of the preoptic anterior hypothalamus |
US6117076A (en) | 1998-09-21 | 2000-09-12 | Belmont Instruments Corporation | Patient monitoring system and method |
US6146411A (en) | 1998-12-24 | 2000-11-14 | Alsius Corporation | Cooling system for indwelling heat exchange catheter |
US6197045B1 (en) | 1999-01-04 | 2001-03-06 | Medivance Incorporated | Cooling/heating pad and system |
CA2356993C (en) | 1999-01-04 | 2009-06-23 | Medivance, Inc. | Improved cooling/heating pad and system |
US6743218B2 (en) * | 1999-01-15 | 2004-06-01 | Cathlogic, Inc. | Retractable catheter systems and associated methods |
US6592577B2 (en) * | 1999-01-25 | 2003-07-15 | Cryocath Technologies Inc. | Cooling system |
US6635053B1 (en) * | 1999-01-25 | 2003-10-21 | Cryocath Technologies Inc. | Cooling system |
US6436295B2 (en) * | 1999-02-11 | 2002-08-20 | Jason Kim | Protein skimmer |
US6554797B1 (en) | 1999-02-19 | 2003-04-29 | Alsius Corporation | Method and system for patient temperature management and central venous access |
US6299599B1 (en) | 1999-02-19 | 2001-10-09 | Alsius Corporation | Dual balloon central venous line catheter temperature control system |
US6719724B1 (en) | 1999-02-19 | 2004-04-13 | Alsius Corporation | Central venous line catheter having multiple heat exchange elements and multiple infusion lumens |
US6585692B1 (en) | 1999-02-19 | 2003-07-01 | Alsius Corporation | Method and system for patient temperature management and central venous access |
US6582398B1 (en) | 1999-02-19 | 2003-06-24 | Alsius Corporation | Method of managing patient temperature with a heat exchange catheter |
US6405080B1 (en) | 1999-03-11 | 2002-06-11 | Alsius Corporation | Method and system for treating cardiac arrest |
ES2183477T3 (en) | 1999-02-19 | 2003-03-16 | Alsius Corp | CENTRAL VENOUS CATHETER PROVIDED WITH A SYSTEM TO CONTROL THE TEMPERATURE. |
US6254567B1 (en) * | 1999-02-26 | 2001-07-03 | Nxstage Medical, Inc. | Flow-through peritoneal dialysis systems and methods with on-line dialysis solution regeneration |
US6217552B1 (en) * | 1999-03-01 | 2001-04-17 | Coaxia, Inc. | Medical device for selective intrathecal spinal cooling in aortic surgery and spinal trauma |
US6019783A (en) | 1999-03-02 | 2000-02-01 | Alsius Corporation | Cooling system for therapeutic catheter |
US6460544B1 (en) | 1999-03-11 | 2002-10-08 | Alsius Corporation | Method and apparatus for establishing and maintaining therapeutic hypothemia |
US6290717B1 (en) | 1999-03-31 | 2001-09-18 | Alsius Corporation | Temperature probe and interconnect cable for hypothermia catheter temperature feedback |
WO2000071072A1 (en) | 1999-05-25 | 2000-11-30 | Viacirq, Inc. | Hyperthermia method and apparatus |
US6579496B1 (en) | 1999-05-25 | 2003-06-17 | Viacirq, Inc. | Apparatus for implementing hyperthermia |
WO2000072779A2 (en) | 1999-05-27 | 2000-12-07 | Alsius Corporation | Apparatus and method for advancing cooling catheter |
US6165207A (en) | 1999-05-27 | 2000-12-26 | Alsius Corporation | Method of selectively shaping hollow fibers of heat exchange catheter |
US6536260B2 (en) | 1999-06-24 | 2003-03-25 | Datascope Investment Corp. | Balloon catheter leak detection method and apparatus |
AU6342400A (en) | 1999-07-08 | 2001-01-30 | Alsius Corporation | Operational enhancements for using cooling catheters |
JP2001029459A (en) | 1999-07-19 | 2001-02-06 | Tomio Ota | Liquid supply system |
US7422601B2 (en) * | 1999-08-02 | 2008-09-09 | University Of Chicago Office Of Technology Transfer | Method for inducing hypothermia |
AU6756300A (en) * | 1999-08-02 | 2001-02-19 | Lance B. Becker | Method for inducing hypothermia |
US6287326B1 (en) | 1999-08-02 | 2001-09-11 | Alsius Corporation | Catheter with coiled multi-lumen heat transfer extension |
US6231594B1 (en) * | 1999-08-11 | 2001-05-15 | Radiant Medical, Inc. | Method of controlling body temperature while reducing shivering |
US6685724B1 (en) * | 1999-08-24 | 2004-02-03 | The Penn State Research Foundation | Laparoscopic surgical instrument and method |
AU7351200A (en) | 1999-09-03 | 2001-04-10 | Alsius Corporation | Method and system for treating high intracranial pressure using hypothermia |
US6447474B1 (en) | 1999-09-15 | 2002-09-10 | Alsius Corporation | Automatic fever abatement system |
US6554791B1 (en) * | 1999-09-29 | 2003-04-29 | Smisson-Cartledge Biomedical, Llc | Rapid infusion system |
US20050154370A1 (en) * | 1999-10-29 | 2005-07-14 | Medtronic, Inc. | Methods and systems for providing therapies into the pericardial space |
US6179624B1 (en) * | 1999-11-05 | 2001-01-30 | Hon Hai Precision Ind. Co., Ltd. | Land grid array connector |
GB9926980D0 (en) | 1999-11-15 | 2000-01-12 | Medivance Instr Limited | Improved pneumatic device |
CA2393221A1 (en) | 1999-12-03 | 2001-06-07 | Neuron Therapeutics, Inc. | Method and apparatus for closed recirculation of synthetic cerebrospinal fluid |
AU4713601A (en) | 1999-12-07 | 2001-06-18 | Alsius Corporation | Method and system for treating stroke using hypothermia |
AU4523301A (en) * | 1999-12-14 | 2001-06-25 | Radiant Medical, Inc. | Method for reducing myocardial infarct by applicaton of intravascular hypothermia |
US6347633B1 (en) * | 2000-01-14 | 2002-02-19 | First Circle Medical, Inc. | Treatment of hepatitis C using hyperthermia |
US6497676B1 (en) | 2000-02-10 | 2002-12-24 | Baxter International | Method and apparatus for monitoring and controlling peritoneal dialysis therapy |
FI110305B (en) * | 2000-02-17 | 2002-12-31 | Instrumentarium Oyj | Device in a monitoring monitor for a patient |
US6648906B2 (en) * | 2000-04-06 | 2003-11-18 | Innercool Therapies, Inc. | Method and apparatus for regulating patient temperature by irrigating the bladder with a fluid |
US6592612B1 (en) * | 2000-05-04 | 2003-07-15 | Cardeon Corporation | Method and apparatus for providing heat exchange within a catheter body |
US6638265B1 (en) | 2000-06-08 | 2003-10-28 | Artin M. Ternamian | Laparoscopy cannula adapter and assembly |
US6726708B2 (en) * | 2000-06-14 | 2004-04-27 | Innercool Therapies, Inc. | Therapeutic heating and cooling via temperature management of a colon-inserted balloon |
AU2001244462A1 (en) | 2000-09-28 | 2002-04-08 | Alsius Corporation | Method of using a central venous line catheter |
US6819950B2 (en) * | 2000-10-06 | 2004-11-16 | Alexander K. Mills | Method for noninvasive continuous determination of physiologic characteristics |
US6530945B1 (en) | 2000-11-28 | 2003-03-11 | Alsius Corporation | System and method for controlling patient temperature |
US6602243B2 (en) | 2000-12-15 | 2003-08-05 | Alsius Corporation | Foley catheter having redundant temperature sensors and method |
US6699268B2 (en) | 2000-12-15 | 2004-03-02 | Alsius Corporation | Radio frequency patient heating system |
US6529775B2 (en) | 2001-01-16 | 2003-03-04 | Alsius Corporation | System and method employing indwelling RF catheter for systemic patient warming by application of dielectric heating |
WO2002058606A1 (en) | 2001-01-24 | 2002-08-01 | Alsius Corporation | Central venous catheter with heat exchange properties |
US6451045B1 (en) | 2001-02-22 | 2002-09-17 | Alsius Corporation | Heat exchange catheter having a helically wrapped heat exchanger |
US6723053B2 (en) | 2001-03-14 | 2004-04-20 | Coopersurgical, Inc. | Esophageal balloon catheter device |
US6572641B2 (en) | 2001-04-09 | 2003-06-03 | Nxstage Medical, Inc. | Devices for warming fluid and methods of use |
US6709448B2 (en) | 2001-04-13 | 2004-03-23 | Alsius Corporation | Open core heat exchange catheter, system and method |
US6641602B2 (en) | 2001-04-13 | 2003-11-04 | Alsius Corporation | Method and device including a colo-rectal heat exchanger |
US6641603B2 (en) | 2001-04-13 | 2003-11-04 | Alsius Corporation | Heat exchange catheter having helically wound reinforcement |
US6461379B1 (en) | 2001-04-30 | 2002-10-08 | Medivance, Incorporated | Localized bodily cooling/heating apparatus and method |
US7756582B2 (en) | 2001-05-01 | 2010-07-13 | Intrapace, Inc. | Gastric stimulation anchor and method |
US6752786B2 (en) * | 2001-05-31 | 2004-06-22 | Radiant Medical, Inc. | Moving heat exchange catheter system |
US6706060B2 (en) | 2001-06-05 | 2004-03-16 | Alsius Corporation | Heat exchange catheter |
US6733517B1 (en) | 2001-06-13 | 2004-05-11 | Alsius Corporation | Angling introducer sheath for catheter having temperature control system |
US7455666B2 (en) | 2001-07-13 | 2008-11-25 | Board Of Regents, The University Of Texas System | Methods and apparatuses for navigating the subarachnoid space |
WO2003008924A1 (en) | 2001-07-18 | 2003-01-30 | Rosenblatt Peter L | Detecting or preventing tissue damage |
US6676409B2 (en) | 2001-08-01 | 2004-01-13 | Medivance Instruments Limited | Dental tool |
US6692519B1 (en) * | 2001-08-06 | 2004-02-17 | Radiant Medical, Inc. | Use of endovascular hypothermia in organ and/or tissue transplantations |
CA2454607C (en) | 2001-08-15 | 2010-04-06 | Innercool Therapies, Inc. | System and method for patient temperature control employing temperature projection algorithm |
US6607517B1 (en) * | 2001-08-24 | 2003-08-19 | Radiant Medical, Inc. | Method of inotropic treatment of heart disease using hypothermia |
US6827702B2 (en) * | 2001-09-07 | 2004-12-07 | Medtronic Minimed, Inc. | Safety limits for closed-loop infusion pump control |
US6911014B2 (en) * | 2001-10-05 | 2005-06-28 | Medical Components, Inc. | Continuous flow peritoneal dialysis catheter |
US6699267B2 (en) | 2001-10-11 | 2004-03-02 | Medivance Incorporated | Patient temperature control system with fluid temperature response |
US6660027B2 (en) | 2001-10-11 | 2003-12-09 | Medivance Incorporated | Patient temperature control system with fluid preconditioning |
US6818012B2 (en) | 2001-10-11 | 2004-11-16 | Medivance, Incorporated | Patient temperature control system with fluid temperature response |
WO2003036612A1 (en) | 2001-10-24 | 2003-05-01 | Pressure Profile Systems, Inc. | Array sensor electronics |
US6800068B1 (en) * | 2001-10-26 | 2004-10-05 | Radiant Medical, Inc. | Intra-aortic balloon counterpulsation with concurrent hypothermia |
WO2003038566A2 (en) * | 2001-11-01 | 2003-05-08 | Scott Laboratories, Inc. | User interface for sedation and analgesia delivery systems and methods |
US6603997B2 (en) | 2001-11-02 | 2003-08-05 | Michael C. Doody | Probe penetration detector and method of operation |
US6807444B2 (en) * | 2001-11-05 | 2004-10-19 | Hosheng Tu | Apparatus and methods for monitoring tissue impedance |
US7383088B2 (en) * | 2001-11-07 | 2008-06-03 | Cardiac Pacemakers, Inc. | Centralized management system for programmable medical devices |
US6572640B1 (en) | 2001-11-21 | 2003-06-03 | Alsius Corporation | Method and apparatus for cardiopulmonary bypass patient temperature control |
WO2003047603A2 (en) * | 2001-12-04 | 2003-06-12 | Minnesota High-Tech Resources, Llc | Breathable gas mixtures to change body temperature |
AU2002243488A1 (en) | 2002-01-09 | 2003-07-30 | Alsius Corporation | Method and system for therapeutic hypothermia |
US7077825B1 (en) * | 2002-01-16 | 2006-07-18 | Radiant Medical, Inc. | Method for gastric cooling using balloon catheter |
US7311690B2 (en) | 2002-02-25 | 2007-12-25 | Novashunt Ag | Implantable fluid management system for the removal of excess fluid |
US6799063B2 (en) | 2002-02-27 | 2004-09-28 | Medivance Incorporated | Temperature control pads with integral electrodes |
US6692518B2 (en) | 2002-02-27 | 2004-02-17 | Medivance Incorporated | Patient temperature control system |
US6648905B2 (en) | 2002-02-27 | 2003-11-18 | Medivance Incorporated | Enhanced medical thermal energy exchange pad |
US6669715B2 (en) | 2002-02-27 | 2003-12-30 | Medivance Incorporated | Medical thermal energy exchange pad |
US7500949B2 (en) * | 2002-03-01 | 2009-03-10 | Medtronic Minimed, Inc. | Multilumen catheter |
US6704590B2 (en) * | 2002-04-05 | 2004-03-09 | Cardiac Pacemakers, Inc. | Doppler guiding catheter using sensed blood turbulence levels |
US6685733B1 (en) | 2002-04-10 | 2004-02-03 | Radiant Medical, Inc. | Methods and systems for reducing substance-induced renal damage |
US7144407B1 (en) | 2002-05-30 | 2006-12-05 | Alsius Corporation | Cardiovascular intra aortic balloon pump catheter with heat exchange function and methods of use |
US6746474B2 (en) * | 2002-05-31 | 2004-06-08 | Vahid Saadat | Apparatus and methods for cooling a region within the body |
US20030225393A1 (en) | 2002-05-31 | 2003-12-04 | Kimberly-Clark Worldwide, Inc. | Low profile transpyloric jejunostomy system and method to enable |
US6852099B2 (en) * | 2002-06-04 | 2005-02-08 | Baxter International Inc. | Device for controllably applying liquids to body surfaces |
US7666213B2 (en) * | 2002-07-11 | 2010-02-23 | Life Recovery Systems Hd, Llc | Apparatus for altering the body temperature of a patient |
US6878156B1 (en) | 2002-07-26 | 2005-04-12 | Alsius Corporation | Portable cooler for heat exchange catheter |
US6827728B2 (en) | 2002-08-08 | 2004-12-07 | Medivance Incorporated | Patient temperature control system |
US6802855B2 (en) | 2002-08-08 | 2004-10-12 | Medivance Incorporated | Patient temperature control system connector apparatus |
US6866638B2 (en) * | 2002-08-12 | 2005-03-15 | Radiant Medical, Inc. | Temperature sensing system with retrograde sensor |
US20040039430A1 (en) | 2002-08-20 | 2004-02-26 | Xanodyne Pharmacal, Inc. | System and method using the rectal mucosal membrane for inducing hypothermia and warming |
US6749625B2 (en) | 2002-08-30 | 2004-06-15 | Alsius Corporation | Intravascular temperature control catheter |
US6796995B2 (en) | 2002-08-30 | 2004-09-28 | Alsius Corporation | Intravascular temperature control catheter |
CA2760543C (en) * | 2002-09-12 | 2013-08-13 | Zoll Circulation, Inc. | System and method for determining and controlling core body temperature |
US20040051368A1 (en) * | 2002-09-17 | 2004-03-18 | Jimmy Caputo | Systems and methods for programming pumps |
EP1558130A4 (en) * | 2002-10-15 | 2009-01-28 | Medtronic Inc | Screening techniques for management of a nervous system disorder |
US6887263B2 (en) * | 2002-10-18 | 2005-05-03 | Radiant Medical, Inc. | Valved connector assembly and sterility barriers for heat exchange catheters and other closed loop catheters |
US20040087606A1 (en) | 2002-11-01 | 2004-05-06 | Voorhees Marc E. | Shivering suppression during cooling to lower body temperature |
CA2411569A1 (en) * | 2002-11-12 | 2004-05-12 | Ross E. Mantle | Medical device for the extravascular recirculation of fluid in body cavities at controlled temperature and pressure |
US7276046B1 (en) * | 2002-11-18 | 2007-10-02 | Biosynergy, Inc. | Liquid conductive cooling/heating device and method of use |
US20040122353A1 (en) * | 2002-12-19 | 2004-06-24 | Medtronic Minimed, Inc. | Relay device for transferring information between a sensor system and a fluid delivery system |
US7278984B2 (en) | 2002-12-31 | 2007-10-09 | Alsius Corporation | System and method for controlling rate of heat exchange with patient |
GB0301934D0 (en) | 2003-01-28 | 2003-02-26 | Sundar Satish | Delivery apparatus and location method |
US7158838B2 (en) | 2003-01-31 | 2007-01-02 | Medtronic, Inc. | Arrangement for implanting a miniaturized cardiac lead having a fixation helix |
US7097657B2 (en) | 2003-02-18 | 2006-08-29 | Alsius Corporation | Dual IV bag arrangement for intravascular temperature control catheter cooling circuit |
US7300453B2 (en) | 2003-02-24 | 2007-11-27 | Innercool Therapies, Inc. | System and method for inducing hypothermia with control and determination of catheter pressure |
AU2003901057A0 (en) | 2003-03-10 | 2003-03-20 | Zsolt Balosh | Intra-abdominal urinary catheter pressure monitor |
US7836881B2 (en) * | 2003-04-28 | 2010-11-23 | Advanced Circulatory Systems, Inc. | Ventilator and methods for treating head trauma and low blood circulation |
US6893454B2 (en) | 2003-04-28 | 2005-05-17 | Alsius Corporation | Intrarectal heat exchange catheter |
US7001418B2 (en) | 2003-04-30 | 2006-02-21 | Alsius Corporation | Intravascular heat exchange catheter with insulated coolant tubes |
WO2004098654A2 (en) | 2003-05-02 | 2004-11-18 | Metolius Biomedical, Llc | Body-space drainage-tube debris removal |
JP4291039B2 (en) | 2003-05-12 | 2009-07-08 | オリンパス株式会社 | Ultrasonic trocar puncture system |
US6872222B2 (en) * | 2003-05-19 | 2005-03-29 | Alsius Corporation | System and method for insulating skin from intravascular heat exchange catheter |
US6921198B2 (en) | 2003-06-12 | 2005-07-26 | Medivance Incorporated | Patient temperature repeating system and method |
US20050033391A1 (en) | 2003-08-06 | 2005-02-10 | Alsius Corporation | System and method for treating cardiac arrest and myocardial infarction |
EP1667620A4 (en) | 2003-08-25 | 2011-05-25 | Medivance Inc | Active body cooling with vasodilation to reduce body temperature |
US20050080832A1 (en) | 2003-09-05 | 2005-04-14 | Stuebe Thomas D. | Esophageal waveform analysis for detection and quantification of reflux episodes |
US8147486B2 (en) | 2003-09-22 | 2012-04-03 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Medical device with flexible printed circuit |
US7270639B2 (en) | 2003-10-14 | 2007-09-18 | Zoll Circulation, Inc. | Temperature regulation system for automatic chest compression housing |
US7693855B2 (en) * | 2003-10-28 | 2010-04-06 | Media Cybernetics, Inc. | Method, system, and computer program product for managing data associated with a document stored in an electronic form |
EP1703922B2 (en) | 2003-12-22 | 2019-12-04 | Medela Holding AG | Drainage apparatus |
JP4832763B2 (en) | 2004-01-20 | 2011-12-07 | エシコン・エンド−サージェリィ・インコーポレイテッド | Access medical device and medical procedure execution method |
US7318834B2 (en) * | 2004-02-09 | 2008-01-15 | Philip Chidi Njemanze | Apparatus and method for hypothermia and rewarming by altering the temperature of the cerebrospinal fluid in the brain |
WO2005104702A2 (en) * | 2004-04-23 | 2005-11-10 | Renal Diagnostic, Inc. | An automated non- invasive real-time acute renal failure detection system |
US7837667B2 (en) * | 2004-09-09 | 2010-11-23 | Plc Medical Systems, Inc. | Patient hydration system with abnormal condition sensing |
US20060064146A1 (en) | 2004-09-17 | 2006-03-23 | Collins Kenneth A | Heating/cooling system for indwelling heat exchange catheter |
US6981945B1 (en) * | 2004-11-12 | 2006-01-03 | Artann Laboratories, Inc. | Colonoscope handgrip with force and torque monitor |
WO2006060248A2 (en) * | 2004-12-03 | 2006-06-08 | Wolfe Tory Medical, Inc. | Pressure and temperature monitoring balloon catheter |
US20060173480A1 (en) | 2005-01-31 | 2006-08-03 | Yi Zhang | Safety penetrating method and apparatus into body cavities, organs, or potential spaces |
US20060190066A1 (en) | 2005-02-23 | 2006-08-24 | Worthen William J | System and method for bringing hypothermia rapidly onboard |
US7070612B1 (en) | 2005-02-23 | 2006-07-04 | Alsius Corporation | System and method for bringing hypothermia rapidly onboard |
EP1695684B1 (en) | 2005-02-25 | 2012-02-15 | Pulsion Medical Systems AG | Enteral feeding catheter, computer system and computer program for operating the feeding catheter |
US7425216B2 (en) | 2005-03-01 | 2008-09-16 | Alsius Corporation | System and method for treating cardiac arrest and myocardial infarction |
US7739907B2 (en) * | 2006-11-29 | 2010-06-22 | Future Path Medical Llc | Container for physiological fluids |
EP2305188B1 (en) | 2005-04-27 | 2015-06-03 | ZOLL Circulation, Inc. | Apparatus for providing enhanced heat transfer from a body |
US7824436B2 (en) | 2005-05-13 | 2010-11-02 | Benechill, Inc. | Methods and devices for non-invasive cerebral and systemic cooling |
US20060276864A1 (en) | 2005-06-03 | 2006-12-07 | Alsius Corporation | Systems and methods for sensing patient temperature in temperature management system |
US7621890B2 (en) | 2005-06-09 | 2009-11-24 | Endocare, Inc. | Heat exchange catheter with multi-lumen tube having a fluid return passageway |
US7181927B2 (en) | 2005-07-01 | 2007-02-27 | Alsius Corporation | Primary heat exchanger for patient temperature control |
US7536218B2 (en) * | 2005-07-15 | 2009-05-19 | Biosense Webster, Inc. | Hybrid magnetic-based and impedance-based position sensing |
US7771362B2 (en) | 2005-08-01 | 2010-08-10 | Datascope Investment Corp. | Calibration of in vivo blood pressure sensors |
US7699799B2 (en) * | 2005-08-26 | 2010-04-20 | Ceeben Systems, Inc. | Ultrasonic material removal system for cardiopulmonary bypass and other applications |
US20070051409A1 (en) | 2005-09-02 | 2007-03-08 | Belmont Instrument Corporation | Pressure responsive fluid flow control valves |
US20070093697A1 (en) * | 2005-10-21 | 2007-04-26 | Theranova, Llc | Method and apparatus for detection of right to left shunting in the cardiopulmonary vasculature |
AU2006337095B2 (en) | 2005-10-21 | 2011-11-03 | Gentherm Medical, Llc | Patient temperature control system with variable gradient warming/cooling |
KR100883555B1 (en) * | 2005-11-15 | 2009-02-17 | 한메딕스 주식회사 | Novel quantitative and qualitative analysis apparatus for measuring the body fluid |
US20080200863A1 (en) | 2005-12-02 | 2008-08-21 | Cabochon Aesthetics, Inc. | Devices and methods for selectively lysing cells |
AU2007205861B2 (en) * | 2006-01-20 | 2013-05-09 | Oculus Innovative Sciences, Inc. | Methods of treating or preventing sinusitis with oxidative reductive potential water solution |
US20090312676A1 (en) | 2006-02-02 | 2009-12-17 | Tylerton International Inc. | Metabolic Sink |
US20070225781A1 (en) | 2006-03-21 | 2007-09-27 | Nidus Medical, Llc | Apparatus and methods for altering temperature in a region within the body |
US20080097179A1 (en) | 2006-07-03 | 2008-04-24 | Russo Susan H | Feeding tube system with reflux fluid sensing |
US7822485B2 (en) | 2006-09-25 | 2010-10-26 | Zoll Circulation, Inc. | Method and apparatus for spinal cooling |
US20080119757A1 (en) | 2006-11-21 | 2008-05-22 | Suzanne Winter | Temperature management system with wireless patient temperature sensor |
US7892270B2 (en) | 2006-11-21 | 2011-02-22 | Zoll Circulation Inc. | Temperature management system and method for burn patients |
EP2094339A4 (en) | 2006-12-01 | 2012-10-17 | Univ Leland Stanford Junior | Devices and methods for accessing the epidural space |
US20080147040A1 (en) * | 2006-12-13 | 2008-06-19 | Medtronic Vascular, Inc. A Delaware Corporation | Catheters Having Linear Electrode Arrays and Their Methods of Use |
US20080154197A1 (en) | 2006-12-20 | 2008-06-26 | Joel Brian Derrico | System and method for regulating the temperature of a fluid injected into a patient |
WO2008107872A2 (en) | 2007-03-02 | 2008-09-12 | Art Healthcare Ltd. | Interactive ngt system |
CA2682035A1 (en) | 2007-03-23 | 2008-10-02 | Thermal Therapeutic Systems, Inc. | Portable hyperthermia apparatus |
JP5259966B2 (en) | 2007-03-26 | 2013-08-07 | 株式会社ジェイ・エム・エス | Oral pressure measuring balloon and method for manufacturing the same |
JP2010523230A (en) | 2007-04-05 | 2010-07-15 | ベロメディックス,インク | Automatic treatment system and method |
WO2008124643A1 (en) | 2007-04-05 | 2008-10-16 | Velomedix, Inc. | Device and method for safe access to a body cavity |
US9333112B2 (en) * | 2007-04-12 | 2016-05-10 | Medivance Incorporated | Sorption-based adhesive contact cooling apparatus and method |
JP5410423B2 (en) | 2007-07-09 | 2014-02-05 | ベロメディックス,インク | Hypothermia apparatus and method |
US8986230B2 (en) | 2007-07-19 | 2015-03-24 | C. R. Bard, Inc. | NG tube with gastric volume detection |
US7819835B2 (en) * | 2007-08-07 | 2010-10-26 | Belmont Instrument Corporation | Hyperthermia, system, method and components |
IL185477A0 (en) | 2007-08-23 | 2008-01-06 | Med I Dynamix Fluid Monitoring | Diagnostic methods and systems based on urine analysis |
EP2211797B1 (en) * | 2007-10-12 | 2020-03-25 | Medivance Incorporated | Improved system for patient temperature control |
WO2009055435A1 (en) | 2007-10-23 | 2009-04-30 | C. R. Bard, Inc. | Continuous intra-abdominal pressure monitoring system |
ES2770309T3 (en) * | 2007-11-16 | 2020-07-01 | Medivance Inc | Control system of the response to the temperature of a patient |
US20100152616A1 (en) | 2007-11-20 | 2010-06-17 | Niyazi Beyhan | Devices and methods for safely accessing bone marrow and other tissues |
WO2009071097A1 (en) | 2007-12-05 | 2009-06-11 | Neurokey A/S | Use of hypothermia inducing drugs |
WO2009071098A2 (en) | 2007-12-05 | 2009-06-11 | Neurokey A/S | Use non-human mammal capable of perspiration for determining the effect of hypothermia inducing drugs in humans |
WO2009071095A2 (en) | 2007-12-05 | 2009-06-11 | Neurokey A/S | Prevention of hyperthermia subsequent to hypothermia treatment of ischemia |
WO2009071096A2 (en) | 2007-12-05 | 2009-06-11 | Neurokey A/S | Combination of medical and physical cooling treatment of ischemic effects |
WO2009071094A2 (en) | 2007-12-05 | 2009-06-11 | Neurokey A/S | Combination treatment of ischemic effects |
US7827005B2 (en) | 2008-04-21 | 2010-11-02 | Zoll Circulation, Inc. | System and method for testing heat exchange system for heat exchange catheter |
WO2012122267A1 (en) | 2011-03-07 | 2012-09-13 | Theranova, Llc | Sensing foley catheter |
EP2344026B1 (en) | 2008-08-28 | 2013-11-06 | Koninklijke Philips N.V. | A device, apparatus and method for obtaining physiological signals by way of a feeding tube |
EP2367470A1 (en) | 2008-11-07 | 2011-09-28 | Velomedix, Inc | Devices and methods for monitoring core temperature and an intraperitoneal parameter |
US20100204765A1 (en) | 2009-02-06 | 2010-08-12 | Hall Gregory W | Method and Apparatus for Inducing Therapeutic Hypothermia |
US8814807B2 (en) | 2009-08-19 | 2014-08-26 | Mirador Biomedical | Spinal canal access and probe positioning, devices and methods |
CA3119878C (en) | 2009-08-19 | 2024-01-09 | Medline Industries, Inc. | Systems, methods, and devices for facilitating access to target anatomical sites or environments |
DK2528575T3 (en) | 2010-01-28 | 2016-08-15 | Art Healthcare Ltd | DEFLECTION DETECTION AND / OR BLOCK DEVICE |
US9622670B2 (en) | 2010-07-09 | 2017-04-18 | Potrero Medical, Inc. | Method and apparatus for pressure measurement |
US9814408B2 (en) | 2010-07-13 | 2017-11-14 | Diversatek Healthcare, Inc. | Display system for displaying conditions of esophageal mucosa and indications of gastroesophageal reflux disease |
US8562524B2 (en) | 2011-03-04 | 2013-10-22 | Flint Hills Scientific, Llc | Detecting, assessing and managing a risk of death in epilepsy |
WO2012103356A2 (en) | 2011-01-26 | 2012-08-02 | Velomedix, Inc. | Dual thermistor redundant temperature sensor |
EP2672903A4 (en) | 2011-02-10 | 2017-07-12 | Actuated Medical, Inc. | Medical tool with electromechanical control and feedback |
US9238126B2 (en) | 2011-04-08 | 2016-01-19 | Sanovas Inc. | Biofeedback controlled deformation of sinus ostia |
US20120277619A1 (en) | 2011-04-29 | 2012-11-01 | Medtronic, Inc. | Detecting food intake based on impedance |
EP3711658A1 (en) | 2011-06-14 | 2020-09-23 | Gravitas Medical Inc. | Apparatus for guiding medical care based on detected gastric function |
US9179971B2 (en) | 2013-02-11 | 2015-11-10 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Printed electrode catheter |
ES2675934T3 (en) | 2014-03-13 | 2018-07-13 | ART MEDICAL Ltd. | Positioning and / or monitoring of combined measurements of a naso / orogastric feeding tube |
US9855186B2 (en) | 2014-05-14 | 2018-01-02 | Aytu Women's Health, Llc | Devices and methods for promoting female sexual wellness and satisfaction |
US9642779B2 (en) | 2014-11-26 | 2017-05-09 | Art Healthcare Ltd. | Closed loop systems and methods for optimal enteral feeding and a personalized nutrition plan |
BR112019011908A8 (en) | 2016-12-12 | 2023-03-07 | Art Healthcare Ltd | SYSTEM TO MANAGE REFLUX DURING ENTERAL FEEDING, COMPUTER IMPLANT METHOD TO MONITOR ENTERAL FEEDING AND MULTI-CHANNEL CONNECTOR |
-
2008
- 2008-04-04 JP JP2010502338A patent/JP2010523230A/en active Pending
- 2008-04-04 AU AU2008237177A patent/AU2008237177A1/en not_active Abandoned
- 2008-04-04 US US12/098,365 patent/US8100880B2/en not_active Expired - Fee Related
- 2008-04-04 WO PCT/US2008/059496 patent/WO2008124644A1/en active Application Filing
- 2008-04-04 CA CA002684807A patent/CA2684807A1/en not_active Abandoned
- 2008-04-04 EP EP08745175A patent/EP2155300A1/en not_active Withdrawn
-
2012
- 2012-01-19 US US13/354,210 patent/US8480648B2/en active Active
-
2013
- 2013-07-08 US US13/937,102 patent/US20130296984A1/en not_active Abandoned
-
2016
- 2016-01-28 US US15/009,687 patent/US20160143774A1/en not_active Abandoned
- 2016-02-02 US US15/013,813 patent/US20170020724A1/en active Pending
-
2018
- 2018-05-30 US US15/993,483 patent/US11800992B2/en active Active
-
2023
- 2023-09-22 US US18/472,625 patent/US20240008763A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2010523230A (en) | 2010-07-15 |
US20080262418A1 (en) | 2008-10-23 |
AU2008237177A1 (en) | 2008-10-16 |
US8100880B2 (en) | 2012-01-24 |
WO2008124644A1 (en) | 2008-10-16 |
US20160143774A1 (en) | 2016-05-26 |
US11800992B2 (en) | 2023-10-31 |
US8480648B2 (en) | 2013-07-09 |
US20170020724A1 (en) | 2017-01-26 |
EP2155300A1 (en) | 2010-02-24 |
US20120116487A1 (en) | 2012-05-10 |
CA2684807A1 (en) | 2008-10-16 |
US20130296984A1 (en) | 2013-11-07 |
US20180289536A1 (en) | 2018-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20240008763A1 (en) | Device and method for safe access and automated therapy | |
US20200016373A1 (en) | Systems, methods, and devices for facilitating access to target anatomical sites or environments | |
EP3797681B1 (en) | Device for facilitating access to target anatomical sites or environments | |
US11172843B2 (en) | Devices and systems for navigation and positioning a central venous catheter within a patient | |
EP2683422B1 (en) | Sensing foley catheter | |
US20080249467A1 (en) | Device and Method for Safe Access to a Body Cavity | |
EP3834722A1 (en) | Micro-movement and gesture detection using radar | |
US20220386961A1 (en) | Vascular access devices, systems, and methods for monitoring patient health | |
EP4182940A1 (en) | Catheter system | |
US20210204818A1 (en) | Diagnostic Systems and Methods Including Temperature-Sensing Vascular Devices | |
US10695484B1 (en) | Systems and methods for lumbar cerebrospinal fluid access and treatment | |
CN219662601U (en) | Sensor deployment system | |
Highton et al. | Intracranial pressure | |
Rucker | Monitoring Critically III Children | |
Bridgland et al. | Monitoring used in the perioperative period |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: THERANOVA, LLC, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BURNETT, DANIEL R.;REEL/FRAME:065046/0986 Effective date: 20180904 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |